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ABSTRACT 
 
Prosthetic infection represents a major problem in the outcome of patients after 
implantation of a foreign body. The presence of biomaterial in the body 
provides a substratum to host either tissue-cell integration or bacterial 
colonization. In obliteration of an infected bone, artificial bone substitutes and 
rigid fixation materials are usually necessary to fill bone cavity and to restore 
the properties of the bone respectively. This study attempted to discover the 
effect of bioactive glass bone substitute granules (BAG) S53P4 on bacterial 
and human-cell adhesion on other implant used simultaneously (I, II). During 
development of new infection-resistant biomaterials, adherence and 
colonization of either bacterial cells or tissue cells on biomaterials must be 
evaluated in parallel. A methodology allowing study of the simultaneous 
growth of bacteria and tissue cells on the same biomaterial surface was 
developed. This will allow discovery of the effect of various bacterial 
concentrations on host-cell viability and integration with an implant surface, 
and their relation to increasing reactive oxygen species (ROS) levels and cell 
apoptosis (III). Finally, considering our first results and that microorganisms 
frequently infect an implant surface during surgery and start to compete for the 
surface before tissue integration, it was hypothesized that incubation of 
implants with host cells before implantation may be one way to reduce the 
bacterial living space available and would prevent bacterial adhesion and 
consequently the infection of biomaterials (IV). 
Bacterial and human osteoblast-like osteosarcoma cells (SaOS-2) or primary 
osteoblast (hOB) cells were incubated for 4.5 hours, 2 days, or 4 days at 37°C. 
As substratum, titanium (Ti), polytetrafluoroethylene (PTFE), polydimethyl-
siloxane (PDMS), or bioactive glass plates (IV) were used. The study was done 
separately (I, II), in competition with SaOS-2 or hOB (III), or in competition 
with SaOS-2 after 24-hour pre-incubation with SaOS-2 (IV). The effect of 
BAG S53P4 on bacteria (I) and cell (II) adhesion was studied in either a normal 
atmosphere or in hypoxia-simulating atmospheric conditions of the middle ear, 
mastoid cavity, or sinuses. Human osteoblast-like SaOS-2 cells or primary 
osteoblast (hOB) cells (III) (both, 1x105cells/mL), and collection strains of 
Staphylococcus aureus and Staphylococcus epidermidis (I) [108 colony 
forming units (CFU) (I) or (serial 1:10 dilutions of 108 CFU (III, IV)] were 
employed. 
The bacteria and cell proliferation, cytotoxicity (III, IV), and production of 
reactive oxygen species (ROS) (III) were evaluated by colorimetric (MTT, 
LDH, and crystal violet) (III, IV) as well as by fluorometric methods 
(fluorescent microscopy and flow cytometry) (III). Bacterial cell viability was 
studied by use of a drop-plate method after sonication. Effects of BAG S53P4 
on cell adhesion were linked intimately with modifications of cellular 
9
 attachment organs (vinculin containing focal adhesions), rearrangement of the 
actin cytoskeleton, and cellular spreading.  
The presence of bioglass under normoxic and hypoxic conditions prevented 
bacterial and biofilm adhesion for most of the materials and promoted 
integration of SaOS-2 cells with various biomaterial surfaces, especially under 
hypoxic conditions, in which S53P4 granules cause increased pH (I, II). In the 
competitive study, the presence of bacteria resulted in reduced adherence of 
human cells to the surface of the biomaterials, increased production of ROS, 
and increased apoptosis. The presence of either type of human cell was 
associated with a reduction in bacteria compared with that for the materials 
incubated with S. aureus only (III). Pretreatment with human cells was also 
associated with a reduction in bacterial colonization of the biomaterial 
compared with that of the non-pretreated materials, but the presence of bacteria 
produced a decrease in viable human cells for all materials (IV). 
In conclusion, the presence of S53P4 granules may both protect implants from 
bacterial colonization and promote their osteointegration. In the presence of 
bacteria and cells, colonization of the surface by one reduces colonization by 
the other. The bacteria produce cellular oxidative stress in human cells, which 
may be related to the cellular death. The preoperative incubation of prostheses 
with host cells could be a new way to prevent infection of biomaterials and 
lessen the risk for bacterial antibiotic resistance. 
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 Introduction 
 
1   INTRODUCTION  
Prosthetic infection stills remains a major challenge to physicians and 
biomedical researchers despite the effective prophylactic measures adopted [1-
3]. The number of implantations is rising, but meanwhile, the focus population 
needing the prosthetic devices or implant materials is aging and suffering from 
comorbidities. Medical implants are highly susceptible to infections, because 
the implant surface itself naturally has no active defense mechanisms. 
Furthermore, there occurs a localized immunological deficit at the interface 
between the implant and the host so that individual microorganisms may attach 
and persist mainly because of the rapid formation of a biofilm resistant to host 
defense and to antimicrobial agents [1, 4-8]. Implant-related infections are 
associated not only with important clinical consequences and patient suffering 
but also with a high economic burden. Their treatment requires a combination 
of long periods of wide-spectrum antibiotic therapy and repeated surgical 
procedures, which involve extended stays in hospital [4, 9].  
Considering the ability of bacteria to persist in multicellular biofilm 
communities, the best way to prevent prosthetic infections is by inhibition of 
biofilm formation. The search for antimicrobial surfaces and materials that can 
resist biofilm formation focuses on incorporating anti-adhesive/antibacterial 
substances into the substratum [6, 10]. The disadvantage is the spread of 
antimicrobial substances which may induce bacterial resistance or cytotoxicity 
in neighboring tissues [11]. The presence of a foreign body automatically 
initiates a “race for the surface” between bacteria and host cells to colonize the 
surface of the implant. Competition occurs between integration of the implant 
into the host tissue and biofilm formation [12]. 
When new biomaterial-coating strategies are under development, tissue 
adaptation and prevention of bacterial adhesion and subsequent infections 
should be explored as separate phenomena. Promotion of tissue integration as 
a means to protect against infection has been poorly studied [13, 14]; this is 
understandable, because bacterial and human cell cultures are traditionally kept 
separate from each other, and simultaneous work with cells and bacteria is 
demanding. 
After medical obliteration of an infected bone, artificial bone substitutes such 
as bioactive glass (BAG), and rigid fixation materials are usually means to 
restore the properties of the bone [15-17]. BAGs of different compositions 
elicit a specific biologic response at the interface of the material, forming direct 
chemical bonds with tissue and enhancing bone tissue formation due to their 
dissolution products, which stimulate osteoprogenitor cells at the genetic level 
[17-19]. The BAG S53P4 is indicated as a bone graft substitute for 
reconstruction of bone defects in treatment of osteomyelitis and craniofacial 
defects caused by mastoidectomy and frontal sinus surgery [20-22]. S53P4, as 
well as other BAGs, possesses antibacterial properties based on several factors, 
including high surface reactivity and ion-release capability. This leads to an 
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alkaline environment and osmotic effects in the surrounding tissues [23, 24]. 
Furthermore, the osteointegration and the bone remodeling form a bone-like 
layer on the surface of S53P4, which inhibits bacterial adhesion and consequent 
biofilm formation [25].  
As a part of the host defense, reactive oxygen species (ROS) are generated and 
released from macrophages and polymorphonuclear granulocytes. ROS react 
against microorganisms, inflicting macromolecular damage on vital cellular 
components. ROS may also react with human cells and extra-cellular 
molecules, inducing apoptosis or even necrosis [26-28]. 
The research project presented here studied the outcome of the race for the 
surface between bacteria and tissue cells and its relation to increasing ROS 
levels and cell apoptosis. The bacterial living space available is reduced on the 
implant through the presence of a bone-like layer on its surface. This is a way 
to prevent bacterial colonization and to avoid use of antibiotic-loaded 
biomaterials, which confers a risk for bacterial antibiotic resistance. This may 
be achieved through the osteoconductive effect of S53P4, which increases the 
bone growth on the implant surface located near to the bioactive glass. Finally, 
considering that microorganisms frequently infect an implant surface during 
surgery and start to compete for the surface before tissue integration, pre-
incubation of biomaterial with host cells before implantation could create an 
antiadherent coating. 
The concept of competition for the surface has been embraced by some 
researchers in the field, but hitherto few in vitro experimental methodologies 
have begun to study the concept thus far. 
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2   REVIEW  OF  THE  LITERATURE  
2.1   OSTEOMYELITIS  AND  INFECTION  OF  BONE  
CAVITIES  
2.1.1   OVERVIEW  
 
Osteomyelitis is an inflammatory process that implies bone destruction and 
necrosis caused by progressive infection of bone. The source of bacterial 
colonization may be an infection in nearby tissue either of post-traumatic or 
post-operative origin, secondary to vascular insufficiency, which occurs 
predominantly in people with diabetes, or due to hematogenous spreading, 
when osteomyelitis has originated from bacteremia [29-31]. The bacterial 
contamination may cause a fulminant infection, but the patient may also be 
symptomless in cases where the replication of the adhered bacteria is hindered. 
After months or even years, acute osteomyelitis can progress to a chronic and 
persistent state, which is characterized by the presence of dead bone 
(sequestrum) and fistulous tracts to the skin. Osteomyelitis leads to a serious 
clinical and economic burden, as it causes thousands of hospital admissions 
each year worldwide. It is often difficult to diagnose and always hard to manage 
due to the heterogeneity of its origin, pathophysiology, and clinical 
manifestation. Successful management of osteomyelitis often requires 
prolonged antibiotic therapy and surgical procedures [32]. 
The cranial air cell system, paranasal sinuses, and mastoid air cells are 
developed by gradual pneumatization of the bone. The cranial air cell system 
provides acoustic properties for hearing, participates in cranial resonance of the 
human voice, reduces the mass of the head, and protects the central nervous 
system from physical damage. Paranasal sinuses also participate in aeration in 
humans beings [33, 34]. Sinusitis and mastoiditis are infections of the paranasal 
sinuses and the mastoid cavity, and both, without early detection and adequate 
treatment, are potential causes of important intracranial complications and 
sepsis [35, 36]. Colonization of the paranasal sinuses by bacteria may lead to 
chronic sinusitis and even lung infections [37], especially in cases with 
compromised local host resistance such as in cystic fibrosis. 
 
 The risk for mastoiditis in typical otitis media has been reduced from 5000-10 
000/100 000 to 5-3.8/100 000/year with the use of antibiotics [35, 38]. In 
developing countries, however, due to the absence of antibiotic treatment, in 
children aged under 5 years, mastoiditis is the most common intratemporal 
complication of acute otitis media (AOM), and mastoiditis is an important 
cause of death [39]. This is the most important fact, considering that AOM is 
the most common localized infection. 
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The common cold is related to the spread of bacterial infection to the 
surrounding cavities, causing bacterial infection of the paranasal sinuses and 
middle ear. One of the complications of middle-ear infection is mastoiditis, 
infection of the mastoid cavity. Sinusitis, infection of the paranasal sinuses, 
may spread to the surrounding soft tissue, most often to the orbita. Infection of 
human body cavities is associated with various symptoms including swelling, 
pressure, and pain in the mastoid process, maxilla, forehead, nose, and around 
the eyes [38]. Acute osteomyelitis often displays an acute suppurative 
inflammation, which reduces local vascular supply and causes development of 
an ischemic area which contributes to bone necrosis in osteomyelitis [30, 31] 
(Figure 1). Osteomyelitis is associated with the presence of clinical symptoms 
such as relapses and fever for longer than 10 days [29-31]. 
 
 
	  
Figure	  1:	  Steps	  in	  the	  process	  from	  acute	  to	  chronic	  osteomyelitis.	  At	  the	  initial	  site	  
of	   infection,	   an	   intracapsular	   infection	   develops,	   accompanied	   by	   an	   area	   of	  
devascularized	   dead	   bone.	   This	   infection	   progresses	   towards	   a	   subperiosteal	  
location,	   which	   leads	   to	   a	   massive	   periosteal	   elevation	   resulting	   in	   new	   bone	  
formation.	  Finally,	  a	  sequestrum	  progresses	  through	  the	  cortical	  bone	  and	  creates	  a	  
cutaneous	  sinus	  tract,	  a	  fistula.	  “Illustration	  by	  author.”	  
2.1.2   OBLITERATION  OF  A  SEQUESTRUM  
 
Obliteration is a surgical procedure intended to debride the necrotic and 
infected bone, mucosa, or air cells. In mastoidectomy, the mastoid air cells are 
debrided, and the empty mastoid cavity thus formed is filled with autologous 
14
 Review of the literature 
 
 
material or bone substitutes. The result is a safe and trouble-free cavity or bone 
(Figure 2). Mastoidectomy implies the formation of an open cavity, allowing 
complete disease visualization and removing the chronically infected bone 
sequester that has resisted other treatments [17, 22, 40-43]. 
 
 
 
	  
Figure	  2.	  Mastoidectomy	  and	  mastoid	  obliteration	  with	  bioactive	  glass	  S53P4:	  a)	  a	  
post-­‐auricular	   incision	   where	   the	   temporalis	   muscle	   was	   dissected	   from	   the	  
underlying	  mastoid	  bone	  from	  the	  mastoid	  tip	  superiorly	  to	  the	  temporal	  line.	  All	  the	  
skin	  lining	  the	  mastoid	  cavity	  was	  removed	  so	  as	  not	  to	  risk	  burying	  a	  cholesteatoma	  
during	  the	  mastoid	  obliteration;	  b-­‐d)	  BAG	  S53P4	  were	  used	  to	  obliterate	  the	  mastoid	  
cavity.	  “Illustration	  by	  author.”	  
 
 
Obliteration can be combined with other surgical treatments where rigid 
fixation materials are intended to reconstruct the bone or the facial contour or 
to restore conductive hearing properties of the middle ear such as in surgical 
cholesteatoma treatment [16, 41, 44, 45].  
2.1.3   ARTIFICIAL  BONE  SUBSTITUTES  
 
In an obliteration, the frontal sinus, skull bone, or other bones are filled with 
suitable material after the complete surgical removal of the pathologic mucosa, 
air cells, or bone tissue. There exists a demand for adequate obliteration 
materials in otolaryngology, as well as in all bone-reconstructive surgery. 
Otolaryngologists and traumatologists have traditionally selected transplanted 
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autologous tissues such as demineralized cranial bone, bone matrix, allogenous 
cancellous bone chips, and cartilage. Each of these, however, shows 
different donor site related problems including morbidity, wound 
complications, immunological rejection, release of calcium into the 
bloodstream, postoperative infections, fat necrosis, and recurrent chronic 
sinusitis [17, 22]. Other possible complications comprise infections related to 
bank tissues, prolongation of surgical procedure time, and complexity of 
surgical technique. All these disadvantages have led to increased interest in 
synthetic materials such as metals (titanium), synthetic polymers such 
as polymethyl methacrylate (PMMA), Proplast or Polytef, ceramics 
(hydroxyapatite), and glasses (bioactive glass S53P4) to induce osteoneo-
genesis in bone defects [42, 43, 46, 47]. 
The prerequisites for biomaterials used in the head and neck area differ from 
those used for joints and long bones, where load-bearing properties are required 
[43]. In the restoration of facial and skull defects that suffer slower bone curing, 
the implant has to fix and maintain the anatomical profile of the reassembled 
area.  
2.1.4   BIOACTIVE  MATERIALS  
 
Bioactive biomaterials induce a specific action in the surrounding cells, 
promoting a binding between tissues and the biomaterial surface, which 
enhances their bioactivity. In bone replacement, they stimulate the osteoblasts 
and bonding of bone tissue leading to the deposition of a bone mineral calcium 
phosphate layer on the implant surface [17, 18, 48, 49]. Bioactive materials are 
served in multiple clinical applications and can be incorporated into the 
structure of such different materials as glasses or ceramics and attaching them 
onto the surface of inert materials such as titanium. Other methods, such as to 
modify the biomaterial surface with biological molecules, can induce a similar 
specific cell behavior [48]. 
 
2.1.4.1   Bioactive  glass  
 
Bioactive glass is a biocompatible, non-toxic, and osteostimulative synthetic 
material, which releases into its environment the ions required for new bone 
formation. Bioactive silica-based glass materials are based on a SiO2–Na2O–
CaO–P2O5–Al3O2–MgO–K2O structure. They serve as bone substitutes or 
fillers, which are implanted into a bone defect [17, 22, 48, 50, 51]. Due to their 
osteostimulative properties, they promote the enrollment and differentiation of 
osteoblasts, they activate osteoblasts to create new bone, and they trigger 
specific osteoblast genes as a response to ion dissolution from the material [20, 
52-54]. In vivo, bioactive glass achieves a natural amorphous hydroxyapatite 
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surface similar to the mineral structure of the bone surface. A silica-rich layer 
deposited on its surface enables direct binding to the bone without any fibrous 
connective tissue interface [20, 22, 48, 50]. Bioactive glass is osteoconductive 
and partially osteoinductive (Figure 3). It acts as a platform for orthotopic bone 
formation but not for ectopic bone formation [20].  
Commercially available BAG compositions are directed toward several clinical 
applications such as bone: the two main products are S53P4 and 45S5. These 
BAGs show different antibacterial, osteoconductive, and angiogenic properties 
as well as different resorption rates in vivo. S53P4 presents a significantly 
slower resorption rate with respect to 45S5 [18, 51, 55, 56]. 
  
2.1.4.2   BAGS53P4  
 
The biologically active response from bioactive materials depends on their 
structural properties and composition [49]. BAG S53P4 is a synthetic silica-
based bone substitute. The name “S53P4” is based on its specific chemical 
composition of 53% SiO2 and 4% P2O5, the rest of the components are 20.0% 
CaO and 23.0% Na2O. It has served in different clinical bone reconstructions 
and obliterations: In otorhinolaryngology it has served in craniofacial 
reconstructions, frontal sinus obliteration after severe chronic sinusitis, in 
mastoid cavity obliteration, and in nasal septum operations [17, 20]. In 
orthopedics, it has served as bone-cavity filling material in the treatment of 
chronic osteomyelitis [17, 20, 40, 50, 57]. In several experimental studies, 
evaluating the use of different artificial bone substitutes in obliteration of 
frontal sinus and other skull defects, BAG S53P4 has produced more new bone 
than does either synthetic hydroxyapatite or tricalcium phosphate [17, 42, 58]. 
 
When a S53P4 bioactive glass surface is exposed to body fluids, sodium, silica, 
calcium, and phosphate ions are released from it inducing the formation of a 
silica gel layer on the surfaces of the glass granules and leading to increased 
local pH and osmotic pressure. This silica gel is based on silanol (Si-OH) 
groups, which are produced by reaction of bioglass silica and protons (H+) 
from the surrounding tissue (Figure 3). Amorphous structures of calcium 
phosphates precipitate and crystalize on natural hydroxyapatite on this layer, 
stimulating migration, replication, and differentiation of osteoblasts for the 
formation of new bone [20, 25, 40, 59]. On the other hand, this ion-dissolution 
process which causes an increase in pH and in osmotic pressure in the 
environment, confers antimicrobial properties on BAG S53P4, as it is more 
harmful and often lethal to prokaryotic structures but not to eukaryotic cells 
[20, 25, 60-65]. BAG S53P4 proved important antibacterial properties against 
46 clinically relevant aerobic and anaerobic bacteria, including methicillin-
resistant Staphylococcus aureus [24, 64, 66]. Lindfors et al. [57] and Sarin et 
al. [22] showed that BAG S53P4 was a good treatment for 11 patients with 
chronic osteomyelitis and a highly effective material in the mastoid obliteration 
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of 25 patients with chronic otitis media. Similar results were obtained by Stoor 
et al. when they evaluated BAGS53P4 in the repair of nasal septum perforations 
in 49 patients and in mastoid obliteration of 7 patients with chronic otitis media 
[15, 67]. S53P4 bioactive glass thus could become a safe and adequate 
alternative to antibiotic-containing PMMA beads in a one-stage procedure in 
treatment of osteomyelitis, avoiding the use of local antibiotics [20, 68]. 
 
 
 
Figure	  3.	  Summary	  of	  bioactive	  glass	  reaction	  mechanisms	  when	  it	  is	  exposed	  to	  body	  
fluids.	   Alkaline	   ions	   are	   released	   causing	   a)	   an	   increasing	   in	   pH	   and	   in	   osmotic	  
pressure	  producing	  antimicrobial	  effect	  b)	  production	  of	   silanol	   (Si–OH)	   functional	  
groups	  on	  the	  bioactive	  glass	  surface	  with	  osteoconductive	  effect	  c)	  an	  activation,	  
enrollment	  and	  differentiation	  of	  osteoblasts	  with	  osteostimulative	  properties.	  
2.2   IMPLANTATION  OF  BIOMATERIALS  
2.2.1   MEDICAL  BIOMATERIALS  
2.2.1.1   History  of  medical  biomaterials  
Just 60 years ago the word “biomaterial” was not used, however since the 
beginning of civilization, man has implanted into human bodies non-biological 
materials in one form or another. Development of material and biological 
science has come a long way. Ancient Egyptians used ligature wire made of 
gold for stabilizing affected teeth (2500 BC). The Mayan population employed 
18
 Review of the literature 
 
 
pieces of shells as a replacement for mandibular teeth (600AD) [69]. In 1860, 
Adolf Gaston Eugen Fick invented the glass contact lens and tested them on 
both animals and humans. Biomaterials were conceived first by Leonardo 
DaVinci in 1508 and later by Rene Descartes in 1632. Two key innovations to 
support the clinical use of biomaterials occurred in the late 1800s with the 
implementation of aseptic operative techniques and the use of x-ray for 
radiography [70].  
In 1829, the first studies assessed in vivo bioreactivity of metallic implant 
materials including gold, silver, lead, and platinum and further studies were 
performed evaluating iron, steel, magnesium, aluminum alloy, zinc, and nickel. 
In 1947, a cobalt-chromium-molybdenum (CoCrMo) alloy was used 
successfully in dentistry after it had shown itself to be well tolerated and strong 
some decades before. In 1947, a possible medical use of titanium and alloys 
was discussed as well. The history of biomaterials was mainly linked to metals, 
and the development of other materials such as plastics and other polymers for 
implant materials does not extend as far back as metals, simply because there 
were few of them prior to the 1940s. 
The biomaterial field has seen accelerating growth since World War II, as 
newly developed high-performance materials invented and manufactured for 
airplanes or other war equipment were applied to medicine. Materials appeared 
such as silicones, polyurethanes, polytetrafluoroethylene (Teflon®), nylon, 
methacrylate, titanium, and stainless steel. During the World War II, Sir Harold 
Ridley, based on observations of the biological effects of shards of airplane 
canopy on the eyes of pilots, developed ocular lens implants from polymer 
materials [70, 71]. 
In 1952, Per Ingvar Brånemark screwed a titanium cylinder into a rabbit bone 
for observing healing reactions, he found this device tightly integrated after 
several months and named this phenomenon “osseointegration”. He promoted 
the use of titanium and its alloys as implants to surgical and dental procedures. 
By 1961, John Charnley developed the first successful low-friction hip 
prosthesis with metallic femoral stem, ball head, and ultra-high molecular 
weight polyethylene (UHMWPE) acetabular cup resulting in good long-term 
results. During 1982–1985, an aluminum and polyurethane artificial heart was 
designed and successfully implanted in a human. Patients lived up to 620 days 
with this Jarvik7® device. From 1990s, nonmetallic implants, part of them 
biodegradable, have taken place and been used first as screws and later even as 
weight bearing implants. At present, metallic alloys, mainly of titanium, as well 
as polymers and ceramic materials are used separately or in combination for 
manufacturing great variation of implants for different tissue types [70, 71]. 
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Figure	  4.	  An	  artificial	  heart	  by	  Étienne-­‐Jules	  Marey,	  Paris,	  1881.	  Figure	  from	  Ratner	  
B,	  Hoffman	  A,	  Schoen	  F,	  Lemons	  J,	  editors.	  Biomaterials	  Science.	  A	  Introduction	  to	  
Materials	  in	  Medicine.	  3rd	  ed.	  Oxford,UK.:	  Academic	  Press	  Elsevier.;	  2013	  [71].	  
2.2.1.2   Definition  
Biomaterials science integrates interdisciplinary research approaches in which 
engineers and physical scientists converge with biologists and clinicians in 
multidisciplinary thinking and analysis. Here interaction of materials with the 
biological environment can solve highly complex problems, enhancing our 
capacity to solve previously untreatable medical conditions [71, 72]. Over the 
years there have been several efforts to define biomaterials science and choose 
the goal of their study. Medical biomaterials are nonviable materials, intended 
to interface with biological systems; they serve to evaluate, treat, augment or 
replace any tissue, organ, or function of the body [70, 71, 73]. Due to the fact 
that most biomaterials induce a foreign body reaction, it is important to 
consider the term “biocompatibility”, which is defined as the ability of a 
material to perform with an appropriate host response in a specific application.  
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Table	  1.	  Key	  applications	  of	   synthetic	  materials	  and	  modified	  natural	  materials	   in	  
medicine.	  Source:	  Buddy	  D.	  Ratner,	  A.S.H.,	  Frederick	  J.	  Schoen,	  Biomaterials	  Science:	  
An	  Introduction	  to	  Materials	  in	  Medicine.	  third	  edition	  ed.	  2013:	  Elsevier	  [71].	  
 
Application Biomaterials used 
Skeletal 
Joint replacements Ti, SS, PE 
Bone fixation plates screws Metals, PLA 
Bone cement PMMA 
Dental implant/tooth fixation Ti 
Cardiovascular 
Pacemaker Ti, PU 
Stent SS, other metals, PLA 
Catheter PTFE, Si, PU 
Organs 
Heart assist device PU, Ti, SS 
Hemodialysis Polysulfone, Si 
Skin substitute Collagen, cadaver skin, nylon, Si 
Otorhinolaryngological 
Cochlear prosthesis Platinum, platinum-iridium, Si 
Ear tubes  Si, PTFE, Ti, Au 
Tracheostomy tubes Si, Ag 
Voice prostheses Si 
Ossicular chain Ti, PMMA 
Other 
Contact lens PA/PMA/Si polymers 
Contact lens PA/PMA/Si polymers 
Intraocular lens PA/PMA 
Breast implant Si 
Mesh Si, PP, PTFE 
Sutures PLA, PDS, PP, SS 
 
Ti: titanium; SS: stainless steel, PE: polyethylene, PLA: poly(lactic 
acid), PMMA: polymethylmethacrylate, PU: polyurethane, Si: silicone, 
PTFE: polytetrafluoroethylene, Au: gold, Ag: silver, PA: acrylate 
polymers, PMA: methacrylate polymers, PP: polypropylene, PDS: 
polydioxanone. 
 
 
Biomaterials cannot be explored without considering medical devices and the 
biological response to them, as they are integrated into devices or implants. 
One example is titanium in conjunction with UHMWP, which becomes the 
device, a hip prosthesis. The success of a device depends on interactions of the 
material: the device has an impact to the recipient (patient), and the patient’s 
host tissue has an impact to the device. Table 1 shows medical devices 
implanted in different medical applications [71]. 
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Four general categories of materials are available as biomaterials: a) metals 
(based on the metallic bond and including pure metals and alloys), b) polymers 
(based on covalent bonds and including glasses, glass–ceramics, and carbons), 
c) ceramics (based on ionic bonds, they are polymers and include ceramics, 
polymers including thermosets, thermoplastics, elastomers and textiles) and d) 
their composites [70, 74].  
2.2.1.3   Metals  
This unique atomic arrangement and bonding enhances the mechanical, 
thermal, and electrical conductivity properties of metals, making them ideal for 
prostheses for hard tissue replacement, fixation devices, and active devices 
such as stents, guide wires, and electrodes. Among metallic biomaterials, 
titanium (Ti) and its alloys are generally preferred to stainless steels and cobalt-
based alloys because of their reduced elastic modulus, enhanced corrosion 
resistance, superior biocompatibility, and low toxicity [75, 76]. The good 
biological properties of Ti and elevated ossointegration are due to the formation 
of the native oxide (TiO2) when Ti is exposed to oxygen [77], otherwise a 
connective tissue capsule would be formed on the bioinert titanium surface 
[49].TiO2 induces formation of a biologically active layer of calcium 
phosphate, which is crucial for integration of prostheses with bone.  
Numerous surface coatings and porous designs from stainless steel, cobalt–
chromium (CoCr), or titanium alloys have been developed as biomaterial 
implants showing excellent clinical results due to enhanced biological fixation 
to bone. However, all of them have several inherent limitations (low volumetric 
porosity, relatively high modulus of elasticity and low frictional 
characteristics). A new totally inert porous tantalum biomaterial, with an 
appearance similar to cancellous bone allows for almost unlimited uses in 
design, shown by the wide variety of available implants and multiple medical 
devices, including pacemaker electrodes, foils, and meshes for nerve repair, 
radio-opaque markers, and cranioplasty plates [78]. 
2.2.1.4   Polymers  
Polymer materials show an array of unique physicochemical properties. The 
number of polymeric materials has increased enormously over the past decade 
and to date they represent the most important class of biomaterials used in a 
large variety of medical applications [79]. These include a huge variation of 
materials and indications such as:  
Polypropylene for sutures, abdominal wall prostheses and intraocular lenses, 
PMMA used in cranioplasties [80-82], silicone in drainage tubes and 
orthopedic surgery [6, 83], composite prostheses of hydroxyapatite-
polyethylene for ossicular chain reconstruction [84], UHMWPE in orthopedic 
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prostheses [85], and polyglycolic acid in mesh reinforcement of 
pancreaticojejunostomy [86].  
Polymers are large molecules composed of linear chains in 3-dimensional 
form. The main characteristic of polymer molecules is their high molecular 
weight. The linear polymer chains are constituted of many covalently linked 
units of alkanes. This carbon chemistry helps to couple them to biological 
interfaces, better than to inorganic materials do, and it can be used for targeted 
interaction to the body. They can be classified as synthetic polymers such as 
the family α-hydroxyacid, which includes poly lactic-co-glycolic acid, 
polyanhydrides, naturally occurring polymers, such as polysaccharides 
including starch, cellulose, chitin, pectin, alginic acid, and inorganics such as 
hydroxyapatite. They can also be classified by function or structure as for 
example hydrogels, injectable, or capable of drug delivery [79]. 
2.2.1.5   Ceramics,  glass  and  glass-­ceramics  
This group includes an extensive spectrum of compositions, useful in different 
medical applications. Insoluble glasses have served as carriers for enzymes, 
antibodies, and antigens, and one designed as a microinjectable drug-delivery 
vehicle for radioactive isotopes [87, 88]. Ceramics and glass-ceramics are 
required in routine dental practice in fabrication of dental prostheses [89]. This 
group of materials is frequently used to repair skeletal hard connective tissues 
and as bone substitutes because of their osteoinductive properties. Some 
examples of this group are aluminium oxide (Al2O3)), bioactive glasses, 
hydroxyapatite, calcium sulfate, and tricalcium phosphate.  
The use of porous ceramic implants is limited to non-loadbearing applications, 
because the porosity of the material is inversely proportional to its strength. 
These materials serve as structural scaffolds due to their inertness and the 
mechanical stability of the intricately developed bone-interface in the pores of 
the ceramic [71]. 
2.3   INFECTION  OF  PROSTHESES  
During recent years, the number of patients who have improved their clinical 
situation because of the implantation of prosthetic devices or implant materials 
is rising, and the targeted population of this medical treatment is aging and 
enduring more comorbidities. For this reason it is logical that the number of 
complications related to the use of these biomaterials also increases, and within 
these complications, the prosthetic infections play a special role due to the 
devastating difficulties they bring about and how difficult they are to treat [1-
3]. Biomaterial infections entail important clinical and economic consequences 
such as prolonged antibiotic treatment, long hospitalizations, and multiple 
surgeries leading in the worst cases to the patient’s death. Despite all the 
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prophylactic measures adopted to avoid these nosocomial infections, they still 
remain as an important clinical challenge for physicians and researchers of 
other areas of science including physics, chemistry, and microbiology [2]. 
The presence of a foreign body offers an adequate surface for bacterial 
adherence, and consequently for development of an infection of the 
surrounding tissue. This situation is favored by implantation surgery in 
differing ways [1]: tissue damage produced by the surgical procedure, 
impairment of the host immune response in the wound tissue, entrapment of 
bacteria by fibrin in the wound (and this protects them against the action of 
antibiotics), seclusion of bacteria in prosthesis interstices, and the development 
of a biofilm on the implant surface [1, 2, 90, 91]. 
2.3.1   RACE  FOR  THE  SURFACE  
In 1988, Anthony Gristina explained clearly that the problem of infections 
related to biomaterials was a rising problem and published his theory: “Race 
for the surface” by which he argued that the presence of a foreign body 
provokes a rivalry between bacteria and host cells to conquer the implant 
surface [12, 92]. Tissue integration on the one hand, and bacterial adherence 
and development of a biofilm on the other are the goals of host cells and 
bacteria respectively (Figure 5). These two phenomena are in conflict, because 
after the adherence of either one, the surface is less vulnerable to colonization 
by the other. Attachment of bacteria to medical materials sparks an 
inflammatory response by the host tissue [93], however, a slimy layer known 
as a biofilm develops that defends the pathogen against host defenses and 
antimicrobial agents [94]. This complicated process is divided into two phases: 
the initial, instantaneous, and reversible bacterial adherence, which is time-
dependent, and biofilm formation, which is irreversible, molecular, and 
independent of time [90, 95, 96].  
This process is influenced by different aspects, including the properties of the 
a) microorganism themselves; in each situation, different bacteria may adhere 
differently to the same biomaterial, b) the target-material surface, as the same 
bacteria may adhere differently to different biomaterials, and c) environmental 
factors, thus same bacteria may adhere differently to the same biomaterial 
depending on circumstances such as medium, pH or temperature [6, 10, 80, 90, 
97-100]. On the other hand, antimicrobial properties and inhibition of bacterial 
colonization of a certain biomaterial in vitro does not ensure antimicrobial 
effect in vivo. 
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Figure	   5.	   Representation	   of	   bacterial	   and	   human	   cells	   adhesion,	   two	   processes	  
competing	  according	  the	  theory	  of	  the	  race	  for	  the	  surface.	  “Illustration	  by	  author.”	  
2.3.1.1   Effects  of  biomaterial  and  microenvironmental  
properties  
With respect to the properties of the biomaterial, we have to consider chemical 
composition, surface charge, hydrophobicity, and the surface roughness or 
physical configuration. These properties can be altered by adsorption of 
proteins and micro environmental properties. 
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2.3.1.2   Host  defenses  and  antimicrobial  agents  
A biofilm protects bacteria against the host defense, antibiotics, and biocides. 
Macrophages and polymorphonuclear granulocytes, through the metabolism of 
oxygen during cell respiration, generate ROS including superoxide-anion 
radicals (•O2-) and hydroxyl radicals (•OH) which are capable of inflicting 
macromolecular damage on vital cellular components [101, 102]. ROS are the 
first line of defense against microorganisms, used to kill the microorganisms 
within phagocytic cells, as they bear highly reactive species due to their single 
unpaired electron. However, as ROS are also released outside the granulocytes, 
their production may be detrimental, because they may react with host cells and 
with extra-cellular molecules: An elevation in ROS that is not controlled by 
antioxidant defenses, may result in oxidative stress, which may stimulate 
pathways leading to apoptosis or even to necrosis [26, 103]. 
Research related to treatment or prevention of prosthesis infections are mainly 
targeted at the development of materials loaded or coated with anti-
adhesive/antimicrobial substances called active coatings. They release pre-
incorporated bactericidal agents such as antibiotics, antiseptics such as silver 
ion or growth factors, chemokines, or peptides that prevent the infection [10, 
60, 104-107]. This method has a very important disadvantage, because the 
dissemination of these bactericidal agents into adjacent tissues could promote 
bacterial resistance or cytotoxicity [11]. A more recent line of research, what 
is called passive coatings, appear promising, since they reduce or prevent 
biomaterial infection by surface chemistry and/or structure modifications, 
enhancing tissue compatibility and integration, or by directly inhibiting 
bacterial adhesion [12, 108-111]. On the other hand, considering that 
microorganisms frequently infect an implant surface during surgery and start 
to compete for the surface before tissue integration some research is focused 
on protection of the prostheses through antimicrobial carriers or coatings 
administered during the surgical procedure [112-114]. 
Tissue integration and bacterial contamination of prostheses and medical 
devices have been mainly investigated as independent phenomena [58, 60, 104, 
115, 116] . These two topics need to be simultaneously investigated during the 
development of new biomaterial-coating strategies because both aspects are 
indispensable in order to achieve a successful long-term outcome [117]. Tissue 
integration in the presence of perioperative bacterial contamination has been 
poorly studied. 
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3   AIMS  OF  THE  STUDY  
Presence of any foreign material in the human body provokes a competition 
between host cells and bacteria to colonize the biomaterial surface, with tissue 
integration and development of infection being their respective goals. These 
infections are very difficult to manage, because the development of a biofilm 
protects the pathogen against the host defenses and antimicrobial agents.  
 
Specific questions to be answered:  
1: Does the presence of BAG S53P4 affect bacterial adherence and biofilm 
formation on the surfaces of different biomaterials in vitro? 
2: Do the hypoxic conditions, resembling the low oxygen levels of human bone 
cavities and the presence of BAG S53P4 affect human cell adhesion on 
different biomaterials? 
3: Does the presence of bacteria affect human cell viability and adhesion to 
different biomaterials, and what are the correlations between the number of 
bacteria, the production of reactive oxygen species, and the number of dead 
cells? 
4: Does preoperative incubation of prostheses with human cells prevent 
bacterial infection of the biomaterials? 
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4   MATERIAL  AND  METHODS  
4.1   BIOMATERIALS  
4.1.1   S53P4  BIOACTIVE  GLASS  GRANULES  (STUDIES  I,  II)  
S53P4 bioactive glass was used in granules sized 0.5 to 0.8 mm and <45 mm 
(BonAlive Biomaterials Ltd., Turku, Finland)(Figure 6). The composition of 
S53P4 by weight is: 53% SiO2, 23% Na2O, 20% CaO and 4% P2O5.  
 
 
 
	  
Figure	  6.	   Sterile	   syringe	   full	   of	  bioactive	  glass	  granules	  bone	   substitute	   for	   filling,	  
replacement	  or	  reconstruction	  of	  bone	  defects.	  
 
 
4.1.2   IMPLANT  PLATES  
Samples were tailored to the surface roughness average (Ra) by use of the same 
SiC abrasive papers (120grit)(Table 2). 
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Table	  2.	  Properties	  of	  the	  different	  materials	  used	  in	  each	  study.	  	  
 
 
Material Size Roughness (Ra) Study 
S53P4 plates 5×5×1.5 mm 500–630 nm I, II 
Titanium 9×9×2 mm 300–400 nm I, II, III, IV 
PDMS 9×9×2 mm 300–400 nm I, II, III 
PTFE 9×9×1 mm 300–400 nm I, II, III, IV 
 
PDMS: polydimethylsiloxane, PTFE: Polytetrafluoroethylene 
 
 
 
S53P4 bioactive glass  
Bulk bioactive glass plates prepared from S53P4 bioactive glass were cut by 
means of a low speed diamond saw provided by the Process Chemistry Centre 
of Åbo Akademi (Turku, Finland).  
 
Titanium  
Titanium plates were produced using titanium deposition by the magnetron 
sputtering system (Stiletto Series ST20, AJA International Inc., North Scituate, 
MA, USA) onto 2-mm-thick 8×10-cm polished glass plates. Samples were cut 
by the EXAKT cutting and grinding system (EXAKT-Apparatebau, Hamburg, 
Germany). 
 
PDMS and PTFE 
PDMS and PTFE plates were cut from industrial polymers (ETRA, Helsinki, 
Finland) of 1-mm and 2-mm thick sheets, respectively.  
4.2   STUDY  CONDITIONS  
4.2.1   THE  pH  STUDY  (STUDIES  I,  II)  
BAG S53P4 granules were added to the different media, and the pH of each 
solution was measured at time-points mentioned in Table 3. The study was 
done in normoxia (0.035% CO2 and 20.9% O2) and hypoxia (7% CO2 and 6% 
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O2) at 37 °C, resembling the situation in the normal middle ear [118-121]. The 
Invivo 2 Hypoxia Workstation (Ruskinn Technologies, Ltd., Sanford, ME, 
USA) (Figure 7) was used to produce the hypoxia. The pH study was done in 
triplicate. 
 
 
Table	  3.	  Description	  of	  the	  different	  media	  used	  in	  Studies	  I	  and	  II	  
  
Medium Ratio (concentration) 
Time of 
measurement Study 
PBS pH 7.4 1/10 (100 mg/mL) 1, 2, and 24 hours I 
McCoy’s 5A 
medium* 1/5 (200 mg/mL) 
4.5 hours, 2 and 4 
days II 
 
*containing 10% fetal calf serum (FCS) and 1% penicillin/streptomycin. 
PBS: phosphate-buffered saline 
 
 
 
 
Figure	  7.	  The	  Invivo	  2	  Hypoxia	  Workstation	  (Ruskinn	  Ltd.,	  Sanford,	  ME,	  USA).	  
4.2.2   CULTURE  OF  STAPHYLOCOCCI  
Two strains of Staphylococcus spp. were used with well-known antibiotic 
susceptibility profiles and a strong biofilm-forming phenotype. Staphylococcus 
aureus 15981 [122] (I, III, IV), isolated at the microbiology department of the 
University Clinics of Navarra, Spain, and the collection strain Staphylococcus 
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epidermidis ATCC 35984 (I) were separately cultured overnight in tryptic soy 
broth (bioMerieux, Marcy l’Etoile, France) at 37º C in a 5% CO2 atmosphere. 
Then the solution with the bacteria was centrifuged for 10 min. at 350 g at room 
temperature, the pellet obtained was washed three times with PBS, and the 
supernatant was removed. The bacteria were suspended and diluted in 10 mM 
sterile PBS to obtain a 108 colony forming units (CFU)/mL suspension. This 
bacterial density was checked according to the McFarland standard by 
measuring the optical density of the bacterial suspension with a 
spectrophotometer at a wavelength of 550 nm (BioMerieux, SA Lyon, France). 
4.2.3   CELL  CULTURE  (STUDIES  II,  III,  IV)  
Human osteosarcoma SaOS-2 cells (ECACC 890500205, Salisbury, Wiltshire, 
UK) (Studies II, III,IV) or primary osteoblasts (hOB) collected aseptically 
during orthopedic knee surgery (Study III) [123] were cultured in 10-cm-
diameter Petri dishes (Corning Inc., Corning, NY, USA) using: a) McCoy’s 5A 
culture medium containing GlutaMAX (Gibco BRL/Life Technologies Inc., 
Gaithersburg, MD, USA) (Study II) or b) minimal essential medium (MEM) 
(Studies III, IV). Both of the media were supplemented with 10% heat-
inactivated fetal bovine serum (FBS) containing 500 IU/mL penicillin and 0.1 
mg/mL streptomycin. Cells were maintained at +37ºC in 20% or 6% O2 in a 
humidified incubator in cell-culture flasks. 
4.2.4   CO-­CULTURE  OF  HUMAN  CELLS  AND  STAPHYLOCOCCI  
(STUDIES  III,  IV)  
To be able to compare the number of human and bacterial cells attached on the 
substrata in co-culture, a suitable media, supporting both eukaryote and 
prokaryote cells, had to be chosen. Three different media were tested, MEM, 
MEM:PBS (1:1) and PBS based on comparison of the numbers of viable SaOS-
2 and S. aureus cells present after 48 h when incubated separately. In order to 
analyze viable human cells the reduction of 3–(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide tetrazolium (MTT) dye was studied, measuring 
optical density at 570 nm, and for bacteria the drop plate method was used. 
MEM:PBS was chosen for two reasons: PBS resulted to be a hostile 
environment for human cells and compared to the other media, there was an 
increase of the number of viable bacteria when S. aureus was incubated in 
MEM.  
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4.2.4.1   Simultaneous  co-­culture  of  staphylococci  and  human  
cells  (studies  III,  IV)  
Ti, PDMS, and 24-well PS cell culture plates were incubated with 105 (SaOS-
2 or hOB) cells per milliliter and with different S. aureus dilutions (107, 106, 
105, 104, 103, and 102 CFU/mL) in a total volume of 2 mL of MEM:PBS (1:1) 
5% FBS, 0.5% L-glutamine, and maintained in co-cultures for 4.5 hours or 48 
hours. The different bacterial densities were obtained from consecutive 1:10 
dilutions from a 108 CFU/mL S. aureus suspension. 
A total of 10 samples of titanium, PDMS, and well plates were incubated with 
each dilution for 4.5 h at 37ºC to analyze cell and bacterial adhesion, or for 48 
hours to study biofilm formation and cell adhesion in a static model. In each 
experiment, a negative control(1 mL of MEM and 1 mL of PBS), bacterial 
control (1 mL of 108 CFU/mL of S. aureus on PBS + 1 mL of MEM), and a 
cellular control (1 mL of 105cells/mL on MEM +1 mL of PBS) were also 
included.  
4.2.4.2   Co-­culture  of  staphylococci  and  pre-­attached  human  
cells  (study  IV)  
First, Ti, PDMS, and 24-well PS cell-culture plates were incubated with 105 
SaOS-2 cells/mL in 2mL of MEM supplemented with 10% heat-inactivated 
FBS and 1% l-glutamine containing 500 IU/mL penicillin and 0.1mg/mL 
streptomycin for 24 hours at +37ºC in 20% or 6% O2 in a humidified incubator. 
Then, the medium was removed, and samples were washed three times with 
PBS to remove any non-adherent human cells. Later, samples with attached 
SaOS-2 cells were incubated with the different dilutions of S. aureus (107, 106, 
105, 104, 103, and 102 CFU/mL) in a total volume of 2 mL of MEM:PBS (1:1) 
5% FBS, 0.5% L-glutamine and maintained in co-cultures for 4.5 hours or 48 
hours. 
A total of 10 samples of titanium, PDMS and well plates were studied in each 
experiment. Each bacterial dilution was covered and incubated at 37°Cfor 4.5 
hours to allow bacterial adhesion or 48 hours of biofilm formation, 
respectively. Each experiment included a negative control, bacterial control, 
and cellular control with 1 mL of 105 cells/mL on MEM + 1 mL of PBS after 
4.5 hours, (24 + 4.5) hours, 48 hours, or (24 + 48) hours. 
 
33
Materials and methods 
4.3   BACTERIAL  ADHERENCE  AND  BIOFILM  
FORMATION  
4.3.1   EFFECT  OF  BAGS53P4  GRANULES  AND  HYPOXIC  
CONDITIONS  (STUDY  I)  
Discs of titanium, PDMS, PTFE, and BAG S53P4 were placed in a bacterial 
suspension diluted to 108 CFU/mL of S. aureus 15981 or S. epidermidis ATCC 
35984 in unpretreated PBS or PBS pretreated for 2 h with S53P4 at a ratio of 
1/10 (100 mg/ml) in the presence of S53P4 granules and in normoxic or 
hypoxic conditions. The bacterial adhesion or biofilm formation were studied 
under four different conditions:(1) unpretreated PBS under normoxia, (2) 
pretreated PBS under normoxia and in the presence of S53P4 granules, (3) 
pretreated PBS under hypoxia, and 4) pretreated PBS under hypoxia and in the 
presence of S53P4 granules. 
4.3.1.1   Bacterial  adhesion  
In well plates, the biomaterial discs were inserted into polycarbonate 
membrane socks (Thermo Scientific Nunc, Goteborg, Sweden) to keep them 
out of direct contact with the S53P4 granules and were incubated in the 
staphylococcal suspension for 90 min at 37ºC under the four different 
conditions. Afterwards, the biomaterial plates were rinsed three times with 
sterile PBS to remove any non-adherent bacteria.  
4.3.1.2   Biofilm  formation  
Biofilm formation was evaluated by the static biofilm method described by 
Buckingham-Meyer et al. [124]. A sample of each of the four materials 
(titanium, PDMS, PTFE, and BAG S53P4) was placed symmetrically on sterile 
filter paper (Whatman qualitative grade 2, GE Healthcare Life Sciences, Little 
Chalfont, UK), which was located on the surface of a tryptic soy agar (TSA) 
plate (Becton–Dickinson, Helsinki, Finland) and inoculated with 1.5 mL of a 
staphylococcal solution of 108 CFU/mL prepared in PBS or S53P4pretreated 
PBS. In the presence of S53P4 granules, these were recovered from the PBS 
pretreated solution and were symmetrically distributed from each plate on top 
of the inoculated filter paper as shown in Figure 8. 
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Figure	  8.	  Static	  biofilm	  method:	  S53P4	  granules	  were	  distributed	  in	  a	  cross	  shape	  in	  
the	  middle	  of	  the	  inoculated	  filter	  paper,	  all	  at	  the	  same	  distance	  from	  samples	  of	  
titanium,	  PTFE,	  PDMS,	  and	  S53P4	  plate.	  The	  diameter	  of	  the	  petri	  dish	  is	  10	  mm.	  
 
 
After 24 hours of incubation at 37ºC, the filter paper was remoistened with 1.5 
ml of 3 g/L (TSB). Plates were incubated for a total of 48 hours. Then, samples 
were rinsed gently in order to remove the non-adhered planktonic bacteria.  
4.3.2   EFFECT  OF  THE  PRESENCE  OF  HUMAN  CELLS  IN  
BACTERIAL  ADHERENCE  AND  BIOFILM  FORMATION  
In Studies III and IV, bacterial adherence and biofilm formation on Ti, PDMS, 
and 24-well PS cell culture plates incubated only with S. aureus were compared 
with results from materials a) pre-incubated with SaOS-2 cells during 24 hours 
or b) in a co-culture with SaOS-2 cells or hOB cells [19]. After a 4.5-hour 
incubation time for bacterial adherence and 48 hours for biofilm formation, 
samples were washed three times with 200mL of PBS to remove non-adherent 
bacteria or cells. 
Finally, to compare properly the results and to take into consideration the 
possible effect of trypsin, all the materials, incubated or not with human cells, 
were treated with 400 µL of trypsin. 
4.3.3   DROP  PLATE  METHOD  (STUDIES  I,  III,  IV)  
As Figure 9 shows, each material plate was placed in 2.5 mL of PBS and 
sonicated for 5 min. in an ultrasonic cleaning bath USC100T (VWR, Leuven, 
Belgium) at 45 kHz with a power output of 300 W. The protocols of Esteban 
et al.[125] and Kobayashi et al were used, which recommend that a sonication 
time of 1to 5 min. is ideal for dislodging biofilm bacteria without affecting 
bacterial viability [126]. After sonication, the number of viable bacteria was 
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determined by the drop-plate method [127]. Bacterial counts obtained under 
the differing conditions of Study I and the number of viable bacteria isolated 
from co-cultures and monocultures (Studies III and IV) were compared. All 
experiments were performed in triplicate for each condition in the comparisons. 
 
 
 
 
Figure	  9.	  Schematic	  representation	  of	  sonication	  and	  drop	  plate	  method	  
4.3.4   Crystal  violet  (studies  III,  IV)  
After 4.5or 48 hours incubation time, the attached bacteria were stained for 15 
minutes with 1% crystal violet. Excess stain was washed off with water, and 
the dye bound to the adherent cells was redissolved in 300 mL of ethanol 95%. 
The absorbance, from aliquots of 200 mL of this solution in 96-well plates, was 
measured at 570 nm wavelength with a Chameleon-V microplate reader [128, 
129].  
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4.3.5   FLUORESCENCE  MICROSCOPY  (STUDY  I)  
Once the plate surfaces were dry, they were covered with the fluorescence stain 
of the Live/Dead BacLight™ Bacterial Viability Kit (Molecular Probes Inc., 
Eugene, OR, USA) [130] for 15 min. A total of 10 fields per plate were 
photographed under a fluorescence microscope (AX70, Olympus, Tokyo, 
Japan) from identical locations according to a premade plan, at x40 
magnification. All experiments were performed in triplicate. The surface area 
covered with adhered bacteria was calculated using the ImageJ software 
(National Institute of Health, Bethesda, MD, USA). 
4.4   ASSESSMENT  OF  CELL  ADHERENCE,  
PROLIFERATION  AND  CYTOTOXICITY  (STUDIES  
II,  III,  IV)  
4.4.1   MICROSCOPIC  ANALYSIS  OF  ATTACHED  CELLS  
(STUDY  II)  
4.4.1.1   Staining  of  vinculin,  actin,  and  nuclei  
After incubation with SaOS-2 cells, the biomaterial plates were washed with 
sterile PBS to remove any nonadherent cells and were treated with 4% 
paraformaldehyde (ChemCruz™, Heidelberg, Germany) and TritonX-100 
(Polyethylene glycol tert-octylphenyl ether) (Sigma, Steinheim, Germany)in 
PBS, in order to fix and permeabilize the cells. Then, Ti, PTFE, PDMS, and 
BAGS53P4 plates were covered first with monoclonal mouse anti-human 
vinculin IgG [131, 132] (1:400 in 0.1 % BSA in PBS), and second with 
Alexafluor 488-conjugated secondary antibody (1:400 in BSA-PBS; Molecular 
Probes, Eugene, OR, USA) for 1 hour and 30 min respectively. The addition of 
Alexafluor 568-conjugated phalloidin (Invitrogen, Carlsbad, CA, USA) and 
4′,6-diamidino-2-phenylindole (DAPI) for nuclear staining (blue color) 
(Invitrogen, Eugene, Oregon, USA) (1:40 dilution in PBS) led to subsequent 
visualization of the actin cytoskeleton and cell nucleus. Finally, the samples 
were mounted on objective slides. 
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4.4.1.2   Immunofluorescence  analysis  of  cell  numbers  and  focal  
adhesions  
DAPI served as the marker for determining the number of attached cells, 
vinculin for focal contact, and actin for evaluating the cellular cytoskeleton and 
for quantifying the size and spreading of cells. Ten photographs were taken 
from the surface of each material incubated for4.5 hours, 2 days, or 4 days 
under the different conditions, using a CCD camera (Nikon Coolpix 8400 
(Nikon, Melville, NY, USA) coupled to a fluorescence microscope (AX70, 
Olympus, Tokyo, Japan) at x20-x40 magnification [104]. Considering a total 
of 30 representative images per material and condition, 40 cells were outlined 
for measuring the cell area using ImageJ software (National Institutes of 
Health, Bethesda, MD, USA). Unfortunately, after 4 days of incubation, it was 
detected that cells overlapped one another, making it impossible to differentiate 
and display these markers. All experiments were performed in triplicate.  
4.4.1.3   Fluorescence  microscopy  
The attached bacteria and/or human cells on plates incubated at different 
proportions during 4.5 hours or 48 hours were stained with acridine orange (BD 
Diagnostics, Sparks, MD, USA) and then photographed from eight fields per 
material. Fluorescent microscope Leica DM6000 B/M (Leica Microsystems, 
Wetzlar, Germany), equipped with a Leica DFC420 digital camera (Leica 
Microsystems, Wetzlar, Germany) and with 20x objective magnification was 
used. 
4.4.2   COLORIMETRIC  METHODS  
4.4.2.1   MTT  assay  for  cell  viability  
SaOS-2 and hOB cell proliferation were analyzed by MTT assay considering 
the ability of viable cells with active metabolism to convert soluble MTT to its 
insoluble purple product, formazan. After incubation in a co-culture of bacteria 
and cells, the culture medium was removed, and samples were incubated for 
four hours in dimethyl sulfoxide (DMSO) (MP Biomedicals, LLC, Illkirch, 
France) containing 10 µL of 5 mg/mL MTT (EMD Millipore Corp., Billerica, 
MA, USA). Later, 300 µL of DMSO was added and, after 2 hours at room 
temperature, absorbance was measured with a CHAMELEON V Multilabel 
Microplate Reader (Hidex, Turku, Finland) with a 570 nm test and 690 nm 
reference wavelengths. 
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4.4.2.2   Lactate  dehydrogenase  (LDH)  cytotoxicity  assay  
 
The percentage of damaged cells was evaluated with a CytoTox 96 non-
radioactive cytotoxicity colorimetric assay (Promega, Madison, WI, USA). 
This measures lactate dehydrogenase (LDH) released into the supernatant 
medium from damaged cells as a biomarker for cellular cytotoxicity and 
cytolysis, through reading absorbance at 490 nm [133, 134]. 
4.4.3   FLOW  CYTOMETRIC  METHODS  
4.4.3.1   Assessment  of  ROS  production  
ROS production was evaluated by studying the fluorescence shown by human 
cells, stained with Cell-ROXTM Deep Red Reagent (Life Technologies, 
Eugene, OR, USA), when subjected to oxidation by ROS (absorption/emission 
maxima at 644/665 nm). Fluorescence emission was analyzed by a BD 
Accuri™ C6 flow cytometer and fluorescence microscopy.  
4.4.3.2   Apoptosis  /  necrosis  detection  kit  
Human cells were stained with the dead cell apoptosis kit containing Alexa 
Fluor488 Annexin V and propidium iodide (PI) (Life Technologies) and 
fluorescence emission was analyzed with a BD Accuri™ C6 flow cytometer at 
530 nm and 575 nm, selecting 1000 events in each sample.  
 
4.5   STATISTICAL  ANALYSIS  
Statistical analyses were performed with four independent experiments per test 
condition. The data are reported as mean  ±  standard deviation (SD) and were 
analyzed with IBM SPSS Statistics for Windows Version 22.0 software (IBM 
Corp., Armonk, NY, USA). Non-parametric tests were used. Mann-Whitney or 
Wilcoxon tests were used for two samples, and the Kruskal-Wallis test for more 
than two samples. Experiments were performed by triplicate. 
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5   RESULTS  
5.1   STUDY  CONDITIONS  
5.1.1   EFFECT  OF  BAG  S53P4  ON  THE  PH  OF  THE  
ENVIRONMENT  
As shown in Figure 10, measured pH values of both the bacteria and cell culture 
medium were measured in the presence of S53P4 granules in both atmospheric 
conditions at: a) 1 hour, 2 hours and 1 day for PBS, and b) 4.5 hours, 2 days, 
and 4 days in McCoy’s 5A medium.  
 
 
 
Figure	  10.	  The	  pH	  of	  :	  a)	  bacteria	  culture	  medium	  (PBS)	  after	  1	  hour,	  2	  hours,	  and	  1	  
day	   or	   b)	   cell	   culture	   medium	   (McCoy’s	   5A)	   at	   4.5	   hours,	   2	   days,	   and	   4	   days	   in	  
normoxia	   and	   hypoxia,	  with	   or	  without	   S53P4	   granules.	   Error	   bars	   represent	   the	  
standard	  deviation	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S53P4 granules raised the pH of both culture media compared with the other 
conditions (P < 0.05, Mann–Whitney test). In contrast, pH was lower in 
hypoxic conditions without any S53P4 granules compared to the other 
conditions (P < 0.05, Mann–Whitney test). 
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Based on the results of MTT, and the drop plate method, shown in Figure 11, 
MEM:PBS (1:1) was selected as the culture medium for these experiments. The 
percentage of viable SaOS-2 cells on the titanium surface in MEM:PBS (1:1) 
was reduced 11% compared with MEM.  
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This, however, was not statistically significant, as Figure 11 shows, with the 
results of optical density for the MTT test (P=0.083, Mann–Whitney test). No 
viable SaOS-2 cells were detectable on titanium in PBS. A higher number of 
viable S. aureus cells was found, by using the drop plate method, on titanium 
incubated in MEM than with MEM:PBS (1:1) or PBS (P=0.021 for all 
comparisons, Mann–Whitney). 
C3+" 72*%,&#21"2(0,&,$*,"2$("7#'/#15"
/'&52%#'$"
9"!"#$ '00'6-$%0$+.<195;7$<(./3,'1$./8$:A;%C)6$
6%/8)-)%/1$=1-38A$)?$
9"!"#"#$ 7:;<>G8:@":KR>A89M"
The presence of S53P4 granules reduced the number of both collection strains 
of Staphylococcus spp. attached to the different materials only with the 
exception of S. aureus incubated with titanium in normoxia (P = 0.061) and S. 
epidermidis with S53P4 plates (P = 0.4918 and P = 0.0712). On the other hand, 
hypoxic conditions reduced the attachment of bacteria to the materials except 
for S. epidermidis on S53P4 plates (P = 0.0992) (Fig.12). 
 
 
 
 
a) 
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Figure	  12.	  a)	  Fluorescent	  microscope	   images	   (×40	  magnification)	  of	  S.	  epidermidis	  
attached	  to	  titanium	  in	  the	  different	  conditions.	  Samples	  were	  stained	  with	  BacLight	  
LiveDead	   stain	   (Molecular	   Probes).	   White	   bar	   represents	   10	   µm.	   b)	   The	   mean	  
percentage	  of	  each	  biomaterial	  surface	  covered	  with	  S.	  aureus	  and	  S.	  epidermidis.	  
Error	  bars	  represent	  the	  standard	  deviation.	  *P < 0.05	  vs.	  all	  the	  other	  conditions.	  	  ▼	  
P < 0.05	  vs.	  HB.	  	  
5.2.1.2   Percentage  of  dead  bacteria  
The proportion of dead bacteria on each biomaterial in different conditions is 
shown in Figure 13. S53P4 granules showed bactericidal effect against both 
collection strains of Staphylococcus spp., but they were effective only for: a) 
both collection strains attached to PDMS in both atmospheric conditions or to 
S53P4 plates in hypoxia and b) S. epidermidis incubated with Ti in normoxia. 
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Moreover, hypoxia induced a bactericidal effect against S. aureus incubated 
with PDMS (P < 0.0001) and S. epidermidis with PTFE (P = 0.018). 
 
 
 
	  
Figure	  13.	  The	  mean	  percentage	  of	  dead	  bacteria	  adhered	  on	  each	  biomaterial	  in	  the	  
different	  conditions,	  a)	  using	  S.	  aureus	  or	  b)	  S.	  epidermidis.	  Error	  bars	  represent	  the	  
standard	  deviation.	  *P < 0.05	  vs.	  all	  the	  other	  conditions.	  ■	  P < 0.05	  vs.	  N	  and	  H.▼	  
P < 0.05	  vs.	  H.	  	  
5.2.1.3   Biofilm  formation  
Figures 14 and 15 show that S53P4 granules diminish biofilm for all materials, 
but reduction in CFU was statistically significant only for S. aureus attached to 
PTFE andS53P4 plates and for S. epidermidis attached to Ti, PDMS, or S53P4 
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plates, for both bacteria in normoxic conditions. This anti-biofilm effect was 
reduced in hypoxia. It occurred for both collection strains attached to Ti, and 
for S. epidermidis on PDMS. 
 
   
!
!
!
!
!
!
!
!
"#$%&'! (I7! N#02#63! 20&34+#0.! 0.! '41/! 34+'&#46! 4.:! 4+30-,/'&#1! 10.:#+#0.! 0.! 4!
60$4&#+/3#1! -146'! R60$e"Zi13DJ! 9!4J!%-#.$!*7! 4%&'%-!0&!<J! *7! ',#:'&3#:#-7! \&&0&! <4&-!
&',&'-'.+!+/'!-+4.:4&:!:';#4+#0.7!jHgkg]7]F!;-7!466!+/'!0+/'&!10.:#+#0.-7!?!Hgkg]7]F!
;-7!n!4.:!Q7?!Hgkg]7]F!;-7!Q7!?!Hgkg]7]F!;-7!n!4.:!nN!
 
Hypoxic conditions produced a decrease in biofilm formation only for S. 
aureus with PTFE (P = 0.0495), and for S. epidermidis with S53P4 plates (P = 
0.0495). Hypoxia caused an increase in biofilm formation on titanium for both 
bacteria (P = 0.0495) and on PDMS for S. epidermidis (P = 0.0495) (Figure 
15). 
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The diminishing of bacterial adherence and biofilm biomass occurred when 
102-108CFU/ml of S. aureus was incubated in co-culture with SaOS-2 cells or 
hOB cells. The only exceptions were a) PS with both human cell types at 4.5 
hours, b) PS, and c) PDMS with hOB cells at 48 h. The diminishing effect was 
stronger with SaOS-2 cells on PE and PDMS than for to hOB cells. Moreover, 
pre-incubation of materials with SaOS-2 cells during 24 h diminished even 
more the bacterial adherence and biofilm biomass compared with the materials 
incubated simultaneously with SaOS-2 cells. This was except for simultaneous 
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co-culture on: a) PS with CFU/mL ≥107 at 4.5 hours, b) titanium with 
CFU/mL  =  108 at 4.5 hours, and c) PS with CFU/mL  =  108 at 48 hours. 
Furthermore, human cells reduced the number of viable bacterial cells in all 
materials incubated with 102-108 CFU/ml of S. aureus with the few exceptions 
including hOB cells on PDMS at 4.5 h. This effect was more pronounced for 
hOB cells than for SaOS-2 cells, with the exception of Ti after 4.5 h and PDMS 
after 48 h. On the other hand, as Figure 16 shows, the pre-incubation of SaOS-
2 cells for 24 h reduced the number of viable bacteria cells in all conditions 
compared with findings for the materials in simultaneous co-culture. 
 
 
 
Figure	  16.	  Fluorescence	  microscope	  images	  (×20	  magnification)	  of	  titanium	  surface	  
incubated	  with	  a)	  S.	  aureus,	  b)	  simultaneous	  co-­‐culture	  of	  SaOS-­‐2	  cells	  and	  S.	  aureus,	  
or	  c)	  with	  SaOS-­‐2	  for	  4.5	  hours	  or	  for	  48	  hours	  (f–h).	  In	  panels	  d,	  e,	  and	  i,	  j,	  SaOS-­‐2	  
cells	  had	  been	  pre-­‐incubated	   for	  24	  hours	  before	  addition	  of	  bacteria.	  Panels	  d,	  e	  
show	  an	  incubation	  time	  of	  4.5	  hours	  and	  i,	  j	  of	  48	  hours.	  The	  samples	  were	  stained	  
with	  acridine	  orange.	  S.	  aureus	  was	  incubated	  at	  a	  concentration	  of	  108	  CFU/mL	  and	  
SaOS-­‐2	  cells	  at	  105	  cells/mL.	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5.2.3   EFFECT  OF  PLATE  MATERIAL  ON  BACTERIAL  AND  
CELLULAR  ADHERENCE  
 
An increase in human cells adhered to Ti was observed when compared to other 
materials at 4.5 h (p  <  0.05) with the exception of hOB cells in the presence of 
≥  103 CFU/mL of S. aureus where there were no statistically significant 
differences. After 48 h, the situation changed: PS and PDMS showed an 
elevation in attached hOB cells or PDMS in SaOS-2 cells; the number of human 
cells adhered to different materials was however, similar with CFU/mL  being 
≥  106 (P  >  0.05). 
 
The increase in bacterial concentration leads to diminishes human cell 
adherence. Considering the SaOS-cells, with their increase in bacterial 
concentration up to CFU/mL ≥  107, the material that favors the most adherence 
always favors all adherence tested, including cells, bacteria, and biofilm mass. 
On the other hand, such correlation for hOB cells was not observed. 
5.3   ASSESSMENT  OF  CELL  ADHERENCE,  
PROLIFERATION  AND  CYTOTOXICITY  (II,  III,  IV)  
5.3.1   EFFECTS  OF  S53P4  BIOACTIVE  GLASS  ON  
OSTEOSARCOMA  (SAOS-­2  )  CELL  AND  BIOMATERIAL-­
SURFACE  INTERACTION  
 
5.3.1.1   Measurement  of  cell  spreading  and  attached  cells  
  
Figure 17 shows cells cultured on titanium for each condition at 4 days, where 
arrangement of the actin cytoskeleton is stained with red phalloidin and nuclei 
stained with blue DAPI. On the other hand, in the same image the effect of 
S53P4 granules on the spreading and the attachment of cells on each 
biomaterial surface under normoxic and hypoxic conditions at 4.5 hours, 2 days 
and 4 days can be seen. 
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At 4.5 hours, the presence of S53P4 granules in normoxic conditions, 
diminished attachment of cells and cell spreading on S53P4 plates and 
increased numbers of attached cells in PTFE. After the same time, in hypoxia, 
the spreading and the attachment of cells increased on titanium and cell 
adhesion rose on S53P4 plates. 
After 2 days, cell spreading increased on S53P4 plates and cell attachment on 
PTFE. In hypoxic conditions, increased cell spreading occurred on PDMS and 
increased attachment of cells in Ti, PTFE, and PDMS. Finally, at 4 days, in 
normoxia, a reduction in cell spreading on PTFE and S53P4 was found, on the 
other hand, the number of cells adhered on PTFE and PDMS increased.  
In general, hypoxic conditions reduced the number of attached cells for all 
materials after different time periods. However, the surface area of cell 
spreading was not clearly affected. Table 4 shows all the P-values. 
Table	  4a.	  P-­‐values	  for	  comparison	  of	  cell	  attachment	  using	  Mann–Whitney	  test.	  	  
  
a)   Mean number of cells attached to material per image 
 Conditions Titanium PTFE PDMS S53P4 
4.5h N vs. NB 0.107 0.201 0.124 0.014 
H vs. HB 0.001 0.076 0.406 0.005 
N vs. H <0.001 <0.001 0.008 <0.001 
2 d N vs. NB 0.066 0.037 0.843 0.07 
H vs. HB <0.001 <0.001 <0.001 0.262 
N vs. H <0.001 <0.001 <0.001 <0.001 
4 d N vs. NB 0.459 ≤0.001 0.049 0.271 
H vs. HB <0.001 <0.001 <0.001 <0.001 
N vs. H <0.001 <0.001 <0.001 <0.001 
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Table	  4b.	  P-­‐values	  for	  comparison	  of	  percentage	  of	  surface	  covered	  by	  40	  cells	  using	  
Mann–Whitney	  test.	  	  
 
 
b)   Mean	  percentage	  of	  surface	  covered	  by	  40	  cells	  per	  image	  
 Conditions Titanium PTFE PDMS S53P4 
4.5 h 
N vs. NB 0.584 0.032 0.052 0.021 
H vs. HB 0.013 0.074 0.277 0.571 
N vs. H 0.303 0.596 0.169 0.508 
2 d 
N vs. NB 0.451 0.283 0.139 0.002 
H vs. HB 0.030 0.491 0.019 0.400 
N vs. H 0.068 0.042 0.149 ≤0.001 
4 d 
N vs. NB 0.169 <0.001 0.102 0.008 
H vs. HB 0.745 0.002 0.160 0.248 
N vs. H 0.139 <0.001 0.725 0.008 
N: Normoxic conditions without S53P4 granules; NB: Normoxic conditions 
with S53P4 granules; H: Hypoxic conditions without S53P4 granules; HB: 
Hypoxic conditions with S53P4 granules. 
5.3.1.2   Vinculin-­containing  adhesion  junctions  
Figure 18) shows vinculin stained focal contacts in the peripheral regions of 
cells attached only on titanium and PTFE surfaces, because of the 
autofluorescence of the PDMS and S53P4 surfaces. Figure 18b shows the 
number of vinculin-stained focal contacts per cell in different conditions. With 
a series of similar results for all time points, a higher number of vinculin-
stained focal contacts at the edge of cells could be visualized: a) attached on 
titanium compared with PTFE, b) in normoxic conditions compared with 
hypoxic conditions (P = 0.026 for titanium and P < 0.001 for PTFE at 2 days; 
P < 0.001 for both materials at 4 days) and c) considering hypoxic conditions, 
in the presence of S53P4 granules (P < 0.001 for both materials at 2 days; P = 
0.004 for Ti and and P < 0.001 for PTFE at 4 days).  
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The number of vinculin-stained focal contacts was unaffected by the presence 
of S53P4 granules in normoxic conditions, with the exception that their 
presence produced a decrease in the number of vinculin-stained focal contacts 
on the PTFE surface at 4 days (P = 0.002). 
At 4.5 h, vinculin-stained focal contacts were observable only at the periphery 
of the cytoplasm of cells cultured on Ti and mainly at the main edges of the 
cells but not in their cellular extensions. After 4.5 h, vinculin-containing focal 
contacts were more numerous and were visible throughout the entire cell 
contours, although they were still at a higher density at the periphery of cells at 
the end-contact points of the actin filament fibers. 
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5.3.1.3   Arrangement  of  the  actin  cytoskeleton  
Figure 19 shows examples of the organization of the actin cytoskeleton in 
SaOS-2 cells attached to the different materials in different conditions and at 
different times. At 4.5 h, only cells attached to titanium, in normoxia, showed 
a polygonal shape and an actin cytoskeleton in the periphery of the cells, but 
without much evidence yet of active spreading. However, cells cultured on all 
other materials still had an immature round shape without any apparent 
organization of the actin cytoskeleton or spreading. 
 
	  
Figure	   19.	   Arrangement	   of	   actin	   cytoskeleton	   of	   SaOS-­‐2	   cells	   cultured	   on	  
polytetrafluoroethylene	   (PTFE),	   titanium	   and	   polydimethylsiloxane	   (PDMS)	   (×40	  
magnification).	   The	   samples	   were	   stained	   with	   Alexafluor	   568-­‐conjugated	  
phalloidin.	  The	  white	  bar	  represents	  20	  μm	  length.	  
After 2 days, a parallel organization of actin filaments building a polygonal 
morphology of SaOS-2 cells was found, although it was most evident on cells 
attached to Ti compared with other materials and in normoxic conditions 
compared to hypoxia. At 4 days the main change compared with 2 days was 
that PTFE and PDMS surfaces showed a more parallel orientation and more 
polygonal morphology of the actin filaments and well-defined stress fiber 
bundles. This situation was less evident in hypoxic conditions but the presence 
of S53P4 may counteract this negative effect on arrangement of the actin 
cytoskeleton, produced by hypoxia, on the PTFE and PDMS surfaces. 
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5.3.2   EFFECTS  OF  BACTERIAL  EXPOSURE  ON  CELL  
PROLIFERATION  AND  CYTOTOXICITY  
5.3.2.1   Cell  proliferation  and  viable  cells  
 
The incubation of S. aureus and human cells (SaOS-2 or hOB) in co-culture on 
Ti, compared with the same biomaterial incubated only with the human cells 
or the bacteria, reduced the proliferation of human cells and the attached S. 
aureus on Ti at 4.5 h and 48 h, as it can be observed in the fluorescence images 
in Figure 20. A significant reduction of cellular proliferation was confirmed by 
an MTT assay and flow cytometry in most of the cases (Figure 21). 
Co-culture with S. aureus CFU/mL  ≥  102 diminished the number of adhered 
SaOS-2 cells (P  =  0.021) in all materials tested, and it was more evident when 
SaOS-2 cells were exposed to S. aureus CFU/mL  >  105. Fluorescence 
microscopy showed that attachment of hOB cells supported better the presence 
of bacteria. Flow cytometry showed that CFU/mL  ≥  102 produced decreased 
numbers of adhered hOB cells at 4.5 h, with the exception of Ti, where this 
reduction started at CFU/mL  ≥  103. Finally, this decrease was also manifest on 
PS incubated with CFU/mL  ≥  102, on Ti and PDMS with CFU/mL ≥  103, all 
when incubated for 48 h. 
When the materials were pre-incubated during 24 hours with SaOS-2 cells and 
thereafter simultaneously incubated with added cells and bacteria, one could 
observe a reduction in the number of viable SaOS-2 cells in the same way that 
was observed in simultaneous co-culture, and, as compared with SaOS cells 
incubated alone (Figure 16); MTT assay showed that an increased bacterial 
density did not reduce cell proliferation, with PS and PDMS (Kruskal-Wallis 
test for PS: P  =  0.685 and P  =  0.100, 4.5 and 48h respectively, and for PDMS: 
P  =  0.158 and 0.246). However, surface incubated with CFU/mL >106 
diminished the number of viable SaOS-2 cells compared with CFU  =  102. 
Finally, the number of viable SaOS-2 cells attached to Ti was unaffected by 
bacterial density in the range of CFU  =  103-108 (P  =  0.187 for 4.5 hours, and 
0.550 for 48 h). 
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Figure	  20.	  Examples	  of	   fluorescence	  microscope	   images	  of	  a)	   the	   titanium	  surface	  
incubated	  with	  S.	  aureus	  only,	  with	  human	  cells	  only,	  and	  in	  co-­‐culture	  with	  S.	  aureus	  
and	  human	  cells	  at	  4.5h:	  a)	  SaOS-­‐2	  cells,	  b)	  hOB	  cells	  and	  48	  h:	  c)	  SaOS-­‐2	  cells,	  d)	  hOB	  
cells.	  The	  samples	  were	  stained	  with	  acridine	  orange.	  S.	  aureus	  was	  incubated	  at	  a	  
concentration	  of	  108	  CFU/mL	  and	  human	  cells	  at	  105cells/mL.	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Figure	  21.	  Fluorescence-­‐activated	  cell-­‐sorting	  (FACS)	  analysis	  of	  (a)	  S.	  aureus,	  SaOS-­‐
2	  cells,	  and	  hOB	  cells	  after	  incubation	  with	  PS	  for	  48	  h.	  FACS	  analysis	  for	  (b)	  SaOS-­‐2	  
and	  hOB	  cells	  with	  PS,	  titanium,	  and	  PDMS	  alone	  or	  incubated	  for	  4.5	  h	  and	  48	  h	  at	  
a	   concentration	   of	   102-­‐108	   CFU/mL	   of	   S.	   aureus.	   Results	   are	   means ± SD	   of	  
experiments	  performed	  in	  quadruplicate.	  *	  P < 0.05	  vs.	  all	  CFU.	  ♦	  P < 0.05	  (≤	  10^4	  CFU	  
vs>	  10^5	  CFU).	  ○	  P < 0.05	  (0	  CFU	  vs	  ≥	  10^3	  CFU)	  (10^2	  CFU	  vs	  10^8	  CFU).▼	  P < 0.05	  (≤	  
10^2	  CFU	  vs	  >	  10^2	  CFU).	  ●	  P < 0.05	  (≤	  10^5	  CFU	  vs	  ≥	  10^6	  CFU).	  ■	  P < 0.05	  (≤	  10^2	  
CFU	  vs	  ≥	  10^3	  CFU)(10^3	  CFU	  vs	  >	  10^4	  CFU)	  (≤	  10^5	  CFU	  vs	  ≥	  10^7	  CFU)	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The collection strain of S. aureus was cytotoxic to SaOS-2 and hOB cells on 
PS, titanium, and PDMS, as demonstrated by increased LDH levels (Figure 
22). In SaOS-2cells, the increase in LDH was visible on PS and PDMS with a 
S. aureus concentration &106CFU/mL and on Ti with a concentration 
%&%107CFU/mL for 4.5 h. In the same way, S. aureus CFU/mL%&%107 increased 
LDH in hOB compared to results with CFU/mL%'%105 except on PS (P%=%0.226). 
On the other hand, only hOB cells showed an elevation in LDH when incubated 
on PDMS with CFU/mL%&%105. 
 
 
 
"#$%&'!DD!4!4.:!<)!YaQ!;46%'-!02!/%34.!1'66-!R*4T*KD!4.:!/TNJ!0.!4J!H*!4.:!<J!>#!#.!
+/'!4<-'.1'!02!<41+'&#4!0&!#.1%<4+':!20&!I7F!/!0&!IW!/!?#+/!*7!4%&'%-!4+!4!
10.1'.+&4+#0.!02!(]DK(]We"Zi3Y7!X'-%6+-!4&'!3'4.-ghg*a!02!'P,'&#3'.+-!,'&20&3':!
#.!@%4:&%,6#14+'7!?!H!k!]7]F!Rq!(]rI!e"Z!;-!u!(]rb!e"ZJ7!l!H!k!]7]F!R(]rD!e"Z!;-u!
(]r_!e"ZJ7!?!H!k!]7]F!Rq!(]rF!e"Z!;-!u!(]r_!e"ZJ7!w!H!k!]7]F!R(]rb!e"Z!;-!(]rW!
a) 
b) 
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Furthermore, there was an elevation in LDH produced by pre-incubated SaOS-
2 cells attached to all materials due to the presence of bacteria. An increase in 
bacterial concentration was not correlated with an increase in cytotoxicity on 
PS (P%=%0.494 and P%=%0.275 for 4.5 hours and 48 hours, respectively) and 
PDMS (P = 0.361 and P = 0.457 for 4.5 hours and 48 hours). Only pre-
incubated SaOS-2 cells attached to titanium for 4.5 hours showed an elevation 
in LDH in the presence of S. aureus&106 CFU/mL (P%=%0.388 for %102-105 
CFU/mL for 4.5 hours and P%=%0.382 for%102-108 CFU/mL for 48 hours). Cell 
cytotoxicity was more evident in the 48-hours experiment compared to 4.5 
hours in the same conditions of staphylococcal density and of material except 
(on)¬ titanium incubated with &107 CFU/mL (P%=%0.248 for%107-108CFU/mL). 
9"5"!"5$ 2P9P<9A8A":MK"M>;G9A8A"9I"RQJ:M";>@@A"PG9=9X>K"LH"<R>"
PG>A>M;>"9I"L:;<>G8:"
The collection strain of S. aureus caused signs of cellular damage in human 
cells (Figure 23). Co-culture with increasing bacterial density up to 
105 CFU/mL caused an increase in the number of cells affected by apoptosis 
and necrosis, contrary to what happens on Ti, where S. aureus diminished the 
c) 
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early stage of apoptosis of hOB cells. At 48 h, the early-stage apoptosis of 
SaOS-2 cells on PS was unaffected by bacteria (P  =  0.327); nevertheless it 
diminished for hOB cells in all materials at bacterial concentrations  >  105 
CFU/mL. The number of cells affected by apoptosis/necrosis increased, 
associated with rising bacterial density, but the number in early apoptotic state 
decreased. 
 
 
 
	  
Figure	  23.	  Fluorescence-­‐activated	  cell	  sorting	  (FACS)	  analysis	  of	  SaOS-­‐2	  cells	   in	  the	  
absence	  of	  bacteria	  and	  in	  co-­‐culture	  with	  103CFU/mL	  or	  108	  CFU/mL	  of	  S.	  aureus.	  
5.3.2.4   Production  of  ROS  
Bacteria provoked an increase in ROS production in both human cell types at 
4.5 h and 48 h (Figure 24) with the unique exception of SaOS-2 cells attached 
to titanium which remained unaffected by bacteria at 4.5 h. Figure 26 shows 
that, after 48 h, there occurred an elevation in ROS released from SaOS-2 cells 
in co-culture with  ≥  103 CFU/mL of S. aureus on titanium, with  >  106 CFU/mL 
on PDMS, and with  108 CFU/mL on PS. 
Considering hOB cells, after 4.5 h, an elevation in ROS was detectable when 
human cells were incubated with  ≥  103 CFU/mL of S. aureus on titanium and 
with  ≥  107CFU/mL on PDMS (P  =  0.021 for all comparisons). After 48 h, the 
presence of S. aureus  ≥  107CFU/mL produced an increase in ROS on both 
titanium and PDMS. 
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Figure	  24.	  Fluorescence	  microscopy	  images	  of	  hOB	  (105cells/Ml)	  incubated	  on	  Ti	  in	  
the	   absence	   or	   presence	   of	   S.	   aureus.	   Staining	   with	   (a)	   acridine	   orange	   or	   (b)	  
CellROX™	  Deep	  Red	  Reagent	  for	  detecting	  ROS.	  	  
5.3.2.5   Relation  between  apoptosis-­necrosis  and  ROS  
A negative correlation between ROS production and the number of SaOS-2 or 
hOB cells suffering from apoptosis and necrosis as a value of lower right (LR)-
apoptosis occurred in the presence of S. aureus on all materials and at all 
bacterial concentrations, with the exception of hOB cells on PS. This 
correlation was visible by the end of the 48-hour experiment; however, after 
the first 4.5 hours it was detected only in SaOS-2 cells attached to titanium and 
hOB cells on PS. 
Similarly, ROS produced by human cells corresponded well with LDH values 
of hOB cells on Ti and PDMS (P  <  0.01 for both materials at 4.5 h and 48 h); 
however, this correlation did not appear for PS and for SaOS-2 cells adhered 
to PS or Ti at 4.5 h and for PDMS at 48 h. 
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6   DISCUSSION  
The introduction of a manufactured medical device into the human body 
represents the starting shot for a race where tissue cells and bacteria compete 
to reach the finish line, which implant-surface colonization represents. The 
outcome of the race is tissue integration or development of implant-related 
infection. Bacteria that colonize the surface build a protective wall known as 
biofilm, which protects them against the host defenses or against antibiotic 
treatment. 
The aim of this thesis was to investigate this race, how the final result can be 
affected by the possible traps used by each of the two competitors, bacteria and 
cells: using more runners or eliminating lanes of the opposing team. This 
research project proposes creating an antiadherent coating on the biomaterial 
surface by placing more human cells in the race. This would reduce the 
bacterial living space available and avoid biomaterial-related infection. 
Osteointegration and infection of a biomaterial depends on attachment, 
adhesion, and spreading of human osteoblastic or bacterial cells on the 
biomaterial surface. These processes are governed by the physico-chemical 
characteristics of the implant and their extra-cellular surroundings [135-138]. 
The hypothesis was that the antiadherent property could be achieved by 
preoperatively incubating the biomaterial with host cells before implantation 
or when the biomaterial is already implanted by inducing the attachment of a 
host tissue layer influenced by the osteoconductive effect of S53P4 located 
around the implant. 
 
6.1   EFFECT  OF  HYPOXIA  ON  BACTERIAL  AND  
CELL  ADHERENCE  TO  PROSTHESES  (I,  II)  
Oxygen level and pH are interdependent, and both influence tissue conditions, 
cellular metabolism, and cell behavior. In this study, hypoxic conditions 
produced a significant decrease in pH of the solution due to the high CO2 levels 
of the hypoxia chamber (7%), which acidifies the medium via formation of 
weak carbonic acid [24]. Hypoxia reduced attachment of both bacteria and 
human cells, reduced vinculin-containing focal adhesion contacts, and 
impaired the formation of a dynamic cellular fiber network of actin filaments. 
Cell spreading and biofilm formation are the next steps: respectively after 
initial attachment of human or of bacterial cells. After the first few hours, 
bacteria and cells adapted themselves to the alterations in the extracellular 
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environment through a metabolic switch which enabled them to adhere and that 
promoted cell spreading and biofilm formation [139]. 
These results go beyond those of previous reports, showing that adaptation to 
hypoxia among pathogenic microorganism such as S. aureus and other 
facultative aerobes is important in order for them to produce virulence factors 
and to develop biofilm in different and often hostile environmental niches [140-
142]. This is not surprising, considering that hypoxia and inflammation are 
coincidental events in a number of chronic infectious diseases, due to the 
metabolic demands of host cells and pathogens. On the other hand, tissues and 
bone cavities are mainly filled with hypoxic air at an oxygen level of around 
6% [120, 121] and at a high CO2 level. Thus, it is logical to think that host cells 
and invading pathogens have developed the capacity to respond to low 
molecular oxygen levels [143, 144]. Furthermore, hypoxia induces gene 
expression that enhances adaptation of both host cells and bacteria, which has 
a significant impact on the development of both infection and inflammation. 
Cell and bacterial culture experiments are normally performed at the 
atmospheric oxygen concentration; this factor may be considered as a potential 
source of error, because in most chronic infections such as in chronic 
mastoiditis, the O2 level is assumed to be low [145, 146]. Thus, it is 
recommended that biomaterial-surface studies should be done also under 
hypoxic conditions. 
The impact of hypoxia on tissue integration and infection of biomaterials 
requires more attention, as it could influence the race for the surface in many 
ways such as by modifying the expression of virulence and antibiotic resistance 
genes [147] or modifying the cellular metabolism [148]. 
6.2   EFFECT  OF  BIOGLASS  TO  BACTERIAL  AND  
HOST  CELLS  (STUDIES  I,  II)  
S53P4 bioactive glass in granule form has shown osteoconductive and 
antimicrobial properties, which may provide a successful strategy for the 
treatment of bone and prosthetic joint infections [20, 31, 149, 150]. The 
effectiveness of S53P4 as a bone substitute in cavitary bone defects, especially 
in craniofacial reconstruction like mastoid obliteration and orbital floor 
reconstruction, has been corroborated in various clinical studies [ 63, 68, 
149,151-153].  
In infected cavities, the acidic environment is devastating for the bone. 
Actually, the pH level and O2 level play a key role in clinical wound infection. 
The accumulation of bacteria leads to increased consumption of oxygen and 
increased hypoxia that in turn produces an acid environment in bone cavities. 
S53P4 neutralizes this acidic environment and exerts an antimicrobial effect, 
which inhibits accumulation of bacteria. In clinical use in infected cavities, it 
may help to prevent the development of bacterial resistance to antibiotics and 
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cytotoxicity or damage to surrounding tissues, because its constituent 
chemicals are all found already in the body [20, 24, 149, 154-156] 
Bone cells are extremely strongly affected by decreased pH. Hypoxic 
conditions lead to an unbalanced acid-base equilibrium in bone because the 
OH(-) ions of hydroxyapatite contained in bone are insufficiently available to 
neutralize the excess of metabolic H(+). Mineral deposition by osteoblasts is 
inhibited by the local acidic environment as well. The negative impact of 
acidosis on the skeleton, because of physiochemical dissolution of bone 
mineral, is bone destruction [157-159]. In cultured osteoblasts, Arnett et al 
described acidosis causing the increased hydroxyapatite solubility and selective 
inhibition of alkaline phosphatase, which is required for mineralization. The 
present experiments show that S53P4 granules shift the acid-base balance in 
the alkaline direction, promoting mineralization through enhancing adherence 
of SaOS-2 cells. In contrast to hypoxic conditions, in normoxia, bioactive glass 
had no effect in vinculin-containing focal-adhesion contacts and the production 
of an actin filament network after the first hours. Brandao-Burch at al. have 
shown that uncorrected acidosis caused by hypoxia blocks the growth and 
differentiation of osteoblasts (and thus bone formation), due to the fact that 
deposition of alkaline mineral in bone by osteoblasts is reduced, and dissolution 
of hydroxyapatite is raised [160]. The result is that the bioglass effect was more 
evident on the initial attachment of bone cells, and cell spreading showed no 
effect from the presence of S53P4 granules in either atmospheric condition. 
S53P4 granules have been able to reduce the bacterial adherence and biofilm 
produced by S. aureus and S. epidermidis on different substrates in vitro. This 
inhibition of bacterial growth is advantageous and has resulted in avoidance of 
infections in implantation of biomaterials in necrotic, chronically infected 
spaces [20, 161]. This agrees with Coraça-Huber et al, who found a clear 
growth-inhibitory effect on S. aureus biofilms by S53P4, although their study 
was conducted only in normoxia [25]. In the present study, S53P4 reduced 
bacterial adhesion in hypoxia. Bacterial cells may be more sensitive, and so 
they suffered damage in alkaline environments [162, 163]; however, bioglass 
shifted the pH close to neutral, and thus other properties may have accounted 
for the antimicrobial effect [164]. These include the increase in osmotic 
pressure [18, 24, 64, 65], physical damage to the cell wall by S53P4 debris, and 
an increase in the ionic strength [165], which is based on a combination of inert 
SiO2 and oxygen radicals generated from bioglass [166-167]. All these 
antimicrobial properties also affect the bacteria that are already adhered to the 
implant surface. Our findings show that the bioglass effect was more evident 
for the attachment of bacteria than for the consequent biofilm formation. 
Biofilm formation was reduced mainly in normoxia, while in hypoxia, the 
reduction of bacterial adhesion was not well correlated with the biofilm 
formation, the same as found by Hu et al. [162]. In some cases, a few bacteria 
were enough to proliferate and develop a mature biofilm due to the biofilm-
promoting effect of the substratum.  
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6.3   EFFECT  OF  BACTERIA  ON  INTEGRATION  OF  
HOST  TISSUE  CELLS  INTO  PROSTHESES  
(STUDY  III)  
The effect of bacterial adhesion and biofilm formation on the tissue integration 
of prostheses has been neglected until the last few years. Bacteria can attach to 
a biomaterial surface at different time points either during the implantation or 
thereafter [168, 169]. A perioperative bacterial contamination model has been 
the choice of most researchers, like Yue et al. In their model, bacterial 
adherence is allowed prior to human-cell adhesion [170-174, 14, 112, 169]. 
Zhao et al. have studied hematogenous spreading of bacteria, which could be 
another route by which cells are attached to a biomaterial surface before 
adhesion of bacteria [169, 171, 175]. However, some biomaterials are 
implanted in contaminated tissue such as an infected cavity, where 
simultaneous competitive adhesion of bacteria and host tissue cells occurs. This 
should, in fact, become an important design parameter for improving implanted 
devices [176, 177].One of the main objectives of this thesis was therefore to 
develop a plausible in vitro approach to the Anthony Gristinas concept of the 
race for the surface, by using a simple experimental setting. [9, 92, 133, 178]. 
Moreover, this model hopes for a fair race, without any advantage such as a 
runner previously located in the biomaterial or a surface doped because of 
favorable culture conditions. In contrast to other researchers such as 
Subbiahdoss et al, who used a modified culture media to avoid dead cells 
[112],this experimental model looks for a fair race, and the culture conditions 
were studied and selected in order to avoid any doping of bacteria or cells in 
the race.  
It seems that in a simultaneous competition between bacteria and human cells, 
the attachment and the viability of either one, on the biomaterial surface, is 
diminished, and this reduction depends on bacterial density. Seven bacterial 
dilutions were tested starting from 102 CFU/cm2 up to 108 CFU/cm2, 
considering that < 102 CFU of S. aureus are needed to infect a prostheses, less 
than half the amount needed for a surgical infection without the presence of an 
implant, and that 108 CFU/cm2 has been selected in several other studies. [80, 
179][10, 180]]. Other researchers such as Subbiahdoss et al. studied only one 
(106 CFU/cm2) or two bacterial densities (102 or 105 CFU/cm2), which does not 
allow estimation of how the bacterial density influences this competition [112, 
172, 181]. In an infection related to the use of biomaterials, less than 102 CFU 
of S. aureus is needed to develop a biofilm and to establish a prosthesis 
infection [179][180]. In multiple studies using high bacterial densities, ≥106 
CFU/mL, researchers have found that a certain biomaterial inhibits bacterial 
growth. However, the clinical importance of such a reduction is questionable 
because the bacterial densities are far from a clinical situation. The infection of 
a prosthesis and poor clinical outcome of a patient is related to the presence of 
biofilm, which can be formed from very low bacterial densities such as 102 
CFU/mL. When enough incubation time is provided, the biofilm grows from a 
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fairly low inoculum. For that reason, studies have used serial 1:10 dilutions 
from 102 CFU/mL up to 108 CFU/mL. 
Cell proliferation occurs at one point in tissue integration of prostheses, and the 
integrated host tissue builds the first line of host defense even in contaminated 
environments [30]. The presence of bacteria reduces human cell attachment 
and damages the cells that have managed to adhere to the biomaterial surface. 
This destructive effect increases with higher concentrations of adhering 
staphylococci, as found by Subbiahdoss et al. and Martinez-Perez et al. [112, 
178]. In contrast to the results of Yue et al. [171] and Lee et al., [182] in the 
present study it was found that also low bacterial densities, as low as 102 
CFU/mL, may diminish cell spreading. Host cells may have an inherent 
mechanism allowing them to compete more effectively against low 
staphylococcal densities, because they seem to be less defective in low 
concentrations [112, 171]. 
Moreover, all human aerobic cells generate ROS against microorganisms, 
through stress-activated pathways; this induces oxidative cell damage also in 
attached bacteria [183, 184]. The problem is that the toxic effect is unselective: 
it can react to any cell, even to the human cells themselves, [112]. This study 
shows a direct correlation between bacterial density, ROS production, 
cytotoxic reaction, and cell death. An overabundance of bacteria may produce 
an uncontrolled inflammatory response with excessive generation of ROS and 
consequent tissue destruction.  
6.4   ANTIMICROBIAL  EFFECT  OF  THE  
PREINCUBATED  HOST  CELLS  (STUDY  IV)  
Considering the theory of Anthony Gristina and earlier results from a 
competitive study involving bacteria and human cells, it was logical to consider 
the promotion of tissue integration to levels beyond complete surface coverage 
as a way to prevent bacterial colonization of a biomaterial. Preincubation with 
host cells having functional host defense mechanisms provides an attractive 
alternative to avoid the devastating consequences of bacterial colonization of 
an implant, also taking into account the emerging problem of bacterial 
resistance to antibiotics [13, 185].  
The promotion of tissue integration has been proposed by some researchers 
such as Dexter et al., who suggest that the presence of ligands on a surface will 
stimulate tissue integration [13]. Their study suggests that, by controlling the 
density of proteins or ligands on a surface, one can potentially optimize 
mammalian cell adhesion without stimulating bacterial adhesion, hence 
reducing the likelihood of an infection. Actually, something similar happens 
with BAG S53P4. Its presence promotes the formation of new bone matrix 
through the release of alkali ions that then become hydroxyapatite [154]. 
Adding the host cells directly on the biomaterial through pre-operative 
incubation before implantation sounds like a very reasonable way to reduce the 
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surface available for circulating planktonic bacteria and consequently to 
prevent infection and biofilm formation. Once osteoblast host cells have 
adhered to the implant surface, it is more difficult for bacterial cells to displace 
them. This is important because of two key points: bacterial cells frequently 
have already started the race for the surface before implantation, and before the 
host cells even reach the starting line; bacterial adhesion leads to formation of 
biofilm which provides resistance to conventional antibiotic therapies and 
necessitates the use of alternative agents [186, 187]. 
6.5   LIMITATIONS  OF  THE  STUDY  
All findings of this project have possible limitations; its methodology involves 
aspects that prevent this model’s being considered identical to pathogenic 
processes of implant-related infections. Various questions, such as the effect of 
protein or another extracellular compound coating the biomaterial surface, are 
still unanswered. Once a biomaterial is implanted in the body, it is in contact 
with the patient’s blood, and its surface is rapidly coated with proteins of 
extracellular fluid such as albumin or fibrinogen. These can inhibit or promote 
bacterial adhesion via specific ligand-receptor interactions [188, 189]. This was 
not considered, because the clinical setting of this project was mastoid-revision 
surgery, accompanied by middle-ear implants to restore conductive hearing. In 
those circumstances, perioperative bacterial attachment mainly occurs on a 
bulk biomaterial substratum located in a dry middle ear. Meanwhile, the 
infected mastoid cavity is revised and filled with bioglass granules. However, 
the addition of whole blood or serum in an in-vitro model of prosthetic infection 
could be interesting and closer to actual physiological conditions. 
 
The main limitation of these experiments is their use of bacterial collection 
strains that are adapted to the laboratory. Wild-type strains would perhaps show 
more virulence against human cells. Martinez-Perez et al. have shown that 
clinical strains isolated from prosthetic infections show great variability and 
different pathogenic properties and adhere to the material surface at lower 
concentrations than do collection strains [178]. This suggests the need for 
studying as many as possible of clinical strains in order to obtain realistic 
results and to better learn bacterial behavior. Based on the promising findings 
presented here, biofilm formation should be studied also using clinical strains 
isolated from prosthetic infections, strains which possess a higher genetic load 
and more pathogenic factors.  
It is important to extend our knowledge of the host immune system to the 
infection itself. The role of phagocytosis in the competition between bacteria 
and osteoblast cells was another aspect not considered. Future research should 
involve macrophages and other cell types such as soft tissue fibroblasts in co-
culture with bacteria and osteoblasts. As PTFE is used more for soft tissue 
implantation, more experiments will be needed to show whether other 
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biomaterials show similar prevention of infection when pre-operatively 
incubated with fibroblasts.  
Future research using other types of cells appears fully justified because it 
could show different types of susceptibility to the presence of ROS. Moreover, 
additional research seeking other signals of cellular stress related to bacterial 
presence remains to be performed. Finally, in vivo animal studies should be 
performed primarily to assess how the attached autologous cells affect the 
tissue integration of the implant and the efficiency with which the S53P4 
produces a change in pH and in osmolarity. 
6.6   ADVANTAGES  AND  DISADVANTAGES  OF  
USING  CELL  THERAPY  INSTEAD  OF  
ANTIBIOTIC  
In this thesis, the possible benefits of cell therapy have been proposed and 
future research should be directed to this field. Once host cells have adhered to 
the implant surface, it is more difficult for bacterial cells to displace them and 
consequently to form biofilm which provides resistance to conventional 
antibiotic therapies and necessitates the use of alternative agents [186, 187]. As 
hypothesized, preoperative incubation of prostheses with human cells prevents 
bacterial infection of the biomaterials since it reduces the surface available for 
circulating planktonic bacteria. With this method one can avoid the use of 
antibiotic or other antimicrobial substances, which could induce bacterial 
resistance or cytotoxicity in neighboring tissues [11].  
These results need to be interpreted with attention towards standardization of 
the cell therapy and their clinical application considering economical aspects. 
Cell therapy could be a complicated and expensive process which should 
include the isolation of host cells, cultivation and freezing. However, it has to 
be considered that biomaterial infections entail important clinical and 
economic consequences such as prolonged antibiotic treatment, long 
hospitalizations, and multiple surgeries, which may in the worst case lead to 
the patient’s death. The first clinical application could be revision operation 
where patient has already suffered a prosthetic infection and in whom it is 
necessary to replace the biomaterial. Bacteria may remain in the patient's 
tissues and could infect the new implant. 
When a biomaterial is implanted into the body, it is cover with extracellular 
fluid containing proteins and cells. Their interaction with preincubated cells is 
still unknown. This cellular covering may promote the adherence of ligands, 
which can lead the race for the surface towards two different directions: 
infection by planktonic bacteria or tissue integration [188, 189].Finally, 
possible immune response from the host against pre-incubated cells should be 
studied. 
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7   CONCLUSIONS 
•   This study shows that S53P4 bioactive glass granules inhibit 
staphylococcal adhesion and biofilm formation on the surfaces of other 
biomaterials in simultaneous use. In vivo this would reduce the risk of 
implant infection. 
•   The use of S53P4 bioactive glass granules compensate the negative effects 
of hypoxic conditions supporting focal adhesion contacts, rearrangement 
of the actin cytoskeleton and cellular adhesion of osteoblast.  
•   This study shows that in the race for the surface between bacteria and 
tissue cells, the presence of either one reduces biomaterial adhesion and 
the viability of the other one; the outcome of this competition depends on 
the initial bacterial density. The presence of bacteria leads to enhanced 
release of ROS from human cells, which correlated well with cell death. 
Excessive inflammation and production of ROS leads to the destruction of 
host tissue. 
•   This study shows that pre-incubation with host cells inhibits the 
attachment of bacteria on implant surface in vitro. As microorganisms 
frequently infect implant surfaces during surgery and start to compete for 
the surface before tissue integration, pre-incubation of biomaterial with 
host cells before implantation could create an antiadherent coating. 
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